Page last updated: 2024-08-23

etoposide and Neutropenia

etoposide has been researched along with Neutropenia in 388 studies

Research

Studies (388)

Timeframe	Studies, this research(%)	All Research%
pre-1990	14 (3.61)	18.7374
1990's	182 (46.91)	18.2507
2000's	132 (34.02)	29.6817
2010's	49 (12.63)	24.3611
2020's	11 (2.84)	2.80

Authors

Authors	Studies
Brown, JR; Davids, MS; Fisher, DC; Ihuoma, U; Jacobson, CA; Lehmberg, TZ; Montegaard, J; Parry, EM; Pazienza, S; Renner, SK; Rogers, KA; Thompson, PA; Tyekucheva, S; Wang, Z; Wu, CJ	1
Cai, Q; Song, W; Sun, X; Wang, L; Wang, Y; Xue, H; Zhang, H; Zhang, L; Zhang, M; Zou, L	1
Hamada, M; Ichikawa, D; Imaya, M; Kawashima, N; Kojima, S; Miwata, S; Muramatsu, H; Narita, A; Narita, K; Nishikawa, E; Nishio, N; Takahashi, Y; Wakamatsu, M; Yamamori, A; Yoshida, T	1
Bullock, TN; Carducci, MA; Gentzler, RD; Hanley, M; Horton, B; Kim, K; Mock, J; Park, KS; Phelps, MA; Piekarz, R; Rhee, JC; Rudek, MA; Rudin, CM; Villaruz, LC	1
Chikasema, M; Chimzimu, F; Chiyoyola, S; Ellis, GK; Fedoriw, G; Gopal, S; Kaimila, B; Kampani, C; Kasonkanji, E; Mhango, W; Montgomery, ND; Mtangwanika, A; Mulenga, M; Nicholas, S; Nyasosela, R; Nyirenda, R; Painschab, MS; Randall, C; Tewete, B; Tomoka, T; Westmoreland, KD; Zuze, T	1
Aboulafia, D; Ambinder, RF; Baiocchi, R; Capoferri, AA; Cesarman, E; Chadburn, A; Durand, CM; Kaplan, L; Lee, JY; Mitsuyasu, R; Moore, PC; Noy, A; Ramos, JC; Ratner, L; Reid, EG; Rubinstein, PG; Siegel, ER; Sparano, JA	1
Cho, HW; Ju, HY; Kim, JH; Koo, HH; Lee, JW; Lim, DH; Shin, HJ; Suh, YL; Sung, KW; Yoo, KH	1
Alifrangis, C; Galazi, M; Gjafa, E; Grunewald, T; Ng, K; Shamash, J; Skyllberg, E; Wilson, P	1
Bartolini, S; Brandes, AA; Franceschi, E; Mascarin, M; Minichillo, S; Mura, A; Tomasello, C; Tosoni, A	1
Ddungu, H; Mulumba, Y; Okello, CD; Omoding, A; Orem, J	1
Ahmed, S; Farah, T; Ghafoor, T; Khalil, S; Sharif, I	1
Appel, W; Ashcroft, L; Barlesi, F; Bezjak, A; Bhatnagar, A; Blackhall, F; Cardenal, F; Faivre-Finn, C; Fournel, P; Harden, S; Le Pechoux, C; Lorigan, P; McMenemin, R; Mohammed, N; O'Brien, M; Pantarotto, J; Snee, M; Surmont, V; Van Meerbeeck, JP; Woll, PJ	1
Han, D; Li, S; Ren, X; Shang, W; Sun, L; Wang, G; Xu, L	1
Claret, L; Copeland, AR; Fanale, MA; Fayad, LE; Feng, L; Fowler, N; Hagemeister, FB; Hu, B; Nastoupil, LJ; Neelapu, S; Nieto, Y; Oki, Y; Rodriguez, MA; Romaguera, J; Samaniego, F; Turturro, F; Westin, JR; Younes, A	1
Gomyo, H; Hiramatsu, Y; Maeda, Y; Masaki, Y; Masunari, T; Matsuo, K; Nakamura, S; Nawa, Y; Nishimori, H; Ohshima, K; Sunami, K; Takahashi, T; Tanimoto, M; Uno, M; Yamane, H; Yano, T; Yoshida, I; Yoshino, T	1
Bompas, E; Bouvier, C; Brisse, HJ; Brugieres, L; Castex, MP; Cheurfa, N; Corradini, N; Delaye, J; Entz-Werlé, N; Gaspar, N; Gentet, JC; Italiano, A; Le Deley, MC; Lervat, C; Marec-Berard, P; Mascard, E; Occean, BV; Pacquement, H; Piperno-Neumann, S; Redini, F; Saumet, L; Schmitt, C; Tabone, MD; Verite-Goulard, C	1
Fukui, T; Igawa, S; Katagiri, M; Kubota, M; Kurahayashi, S; Mitsufuji, H; Naoki, K; Nishinarita, N; Okuma, Y; Ono, T; Ozawa, T; Sasaki, J; Shirasawa, M; Sone, H; Sugimoto, A; Sugita, K	1
Allan, E; Ayan, A; Barney, CL; Bazan, JG; DiCostanzo, D; Grecula, J; Haglund, KE; Otterson, GA; Scoville, N; Williams, T; Xu-Welliver, M	1
Anzai, M; Goto, N; Ishizuka, T; Kadowaki, M; Kodawara, T; Morikawa, M; Nakamura, T; Negoro, Y; Suehiro, Y; Tsukamoto, H; Umeda, Y; Watanabe, K; Yamashita, S; Yano, R; Yoshimura, M	1
Alnassan, A; Elshahoubi, A; Sultan, I	1
Blijlevens, NM; de Haan, AF; Donnelly, JP; Herbers, AH; van der Velden, WJ	1
Mulchandani, M; Sankaranarayanan, A; Tirupati, S	1
Mullen, EC	1
Chen, X; Li, W; Ma, KW; Wang, X; Wang, YZ	1
Chakravarty, A; Mettetal, JT; Palani, S; Patel, M; Shyu, WC; Yang, J	1
Huang, H; Kang, H; Li, C; Peng, B; Peng, Y; Wang, D; Xiong, Y; Xu, M; Yang, X; Zhou, Z	1
Dedecjus, M; Lech-Marańda, E; Pielaciński, K; Prochorec-Sobieszek, M; Szczepanik, AB; Warzocha, K	1
Bianco, V; Francini, E; Ghiribelli, C; Laera, L; Luzzi, L; Martellucci, I; Paladini, P; Petrioli, R; Roviello, G; Voltolini, L	1
Jiang, Z; Liu, R; Shen, Z; Wang, P; Yao, Y; Zhu, J	1
Gomez, D; Komaki, R; Lee, MS; Levy, LB; Liao, Z; Lu, C; Tang, C; Zhuang, Y	1
Fang, J; Liu, LF; Wu, MJ; Yin, ZM; Yu, AJ; Yu, H; Zhu, JQ	1
Aoyagi, H; Chubachi, S; Ikemura, S; Iwami, E; Matsuzaki, T; Nakajima, T; Terashima, T	1
Hotta, T; Kubo, K; Miyazaki, Y; Murayama, T; Shimazaki, R; Tamura, K; Urabe, A; Usui, N	1
Cheng, Y; Cui, HX; Li, ZL; Ma, LX; Sun, SY; Yang, CL	1
Aerts, J; Akerley, W; Fairchild, J; Felip, E; Gold, K; Havel, L; Horn, L; Kim, SW; Kong Sanchez, T; Lorigan, P; Luft, A; Nakagawa, K; Pietanza, MC; Pieters, A; Reck, M; Spigel, D; Szczesna, A; Thomas, M; Wu, YL; Zielinski, C	1
Adachi, S; Arakawa, Y; Funaki, T; Heike, T; Hiramatsu, H; Mizowaki, T; Nodomi, S; Saida, S; Ueno, H; Umeda, K	1
Chow, L; Eckhardt, SG; Gore, L; Lieu, C; Morrow, M; O'Bryant, CL; Pierson, AS; Tran, ZV; Wright, JJ	1
Gil, L; Komarnicki, M; Kozlowska-Skrzypczak, M; Mol, A; Poplawski, D; Styczynski, J	1
Grenader, T	1
Han, XH; He, XH; Li, B; Liu, P; Shi, YK; Yang, JL; Yang, S; Zhang, CG; Zhou, SY	1
Friberg, LE; Karlsson, MO; Wallin, JE	1
Fouladi, M; Furman, WL; Ivy, P; Laningham, FH; McGregor, LM; Santana, VM; Spunt, SL; Stewart, CF; Ward, DA; Watkins, A	1
Aerts, JG; Gras, J; Hoogsteden, H; Pouw, E; Pronk, T; Salomé, J; Schmitz, PI; Surmont, V; Tan, KY; van Klaveren, RJ; Vernhout, R	1
Carleton, JE; Chansky, K; Crowley, J; Dakhil, SR; Gandara, DR; Jett, J; Kuebler, JP; Langer, CJ; Lara, PN; Lenz, HJ; Natale, R; Redman, MW	1
Beaven, AW; Chao, N; Gabriel, DA; Garcia, RA; Gockerman, JP; Moore, DT; Rizzieri, DA; Serody, JS; Shea, TC	1
Crowley, JJ; Gandara, DR; Gaspar, LE; Goldberg, Z; Lara, PN; Le, QT; Moon, J; Moore, DF; Redman, M; Williamson, SK	1
Bulusu, R; Camilleri, D; Follows, G; Marcus, R; Raj, S; Stafford, G; Todd, T; Williams, M	1
Romanick, M; Shiu, JR; Stobart, K	1
Fujigaki, H; Hoshi, M; Ito, H; Ohtaki, H; Ohyama, M; Saito, K; Seishima, M; Takahashi, T; Takemura, M; Tanaka, R; Tomita, E	1
Hongo, H; Inui, K; Kishi, Y; Kodawara, T; Takahashi, J; Yano, I; Yano, Y	1
Boddy, AV; Cole, M; Ellershaw, C; Errington, J; Gerrard, M; Pearson, AD; Veal, GJ; Whyman, G	1
Blakely, J; Ciuleanu, T; Dediu, M; Guba, SC; Hanauske, AR; Hong, S; Jassem, J; Karaseva, NA; Konduri, K; Lorigan, P; Obasaju, CK; Reck, M; Serwatowski, P; Smit, EF; Socinski, MA; Szczesna, A; Thatcher, N; Visseren-Grul, C	1
Chelis, L; Christophyllakis, Ch; Georgoulias, V; Giassas, S; Kakolyris, S; Kalykaki, A; Kentepozidis, N; Kotsakis, A; Polyzos, A; Vamvakas, L; Vardakis, N; Xenidis, N	1
Glisson, BS; Johnson, FM	1
Agha, M; Boyiadzis, M; Foon, KA; Luong, TM; McHayleh, W; Natale, J; Raptis, A; Redner, RL; Schlesselman, JJ; Sehgal, R	1
Bui, B; Coindre, JM; Garbay, D; Italiano, A; Kantor, G; Kind, M; Lortal, B; Stoeckle, E; Toulmonde, M	1
Blumenschein, GR; Feng, L; Fossella, FV; Glisson, BS; Johnson, FM; Karp, DD; Peeples, BO; Stewart, DJ; Uyeki, J; William, WN	1
Bessho, M; Hagiwara, Y; Kohri, M; Niitsu, N; Okamoto, M; Takahashi, N; Tanae, K	1
Dunleavy, K; Tay, K; Wilson, WH	1
Asmar, L; Beveridge, R; Boehm, KA; Mandanas, R; McGaughey, D; Orloff, G; Rifkin, R; Spitzer, G; Zhan, F	1
Barraco, F; Cannas, G; Chelghoum, Y; Derbel, O; Elhamri, M; Le, QH; Michallet, M; Nicolas-Virelizier, E; Nicolini, F; Thomas, X; Troncy, J	1
Bodiagin, DA; Pokrovskiĭ, VS; Treshchalin, MI; Treshchalina, EM	1
Billaud, EM; Bobin-Dubigeon, C; Boisdron-Celle, M; Boyer, JC; Chatelut, E; Concordet, D; Durdux, C; Etienne-Grimaldi, MC; Evrard, A; Floquet, A; Gladieff, L; Laffont, CM; Lafont, T; Lansiaux, A; Le Guellec, C; Mazières, J; Mousseau, M; Ollivier, F; Pinguet, F; Schmitt, A	1
Bazan, F; Chaigneau, L; Demarchi, M; Dobi, E; Ivanaj, A; Kalbacher, E; Maurina, T; Montange, D; Nguyen, T; Pivot, X; Royer, B; Thiery-Vuillemin, A; Villanueva, C	1
Cai, Q; Huang, H; Jiang, W; Lin, X; Lin, Z; Xia, Z	1
Agatsuma, T; Hanaoka, M; Ito, M; Kanda, S; Koizumi, T; Kubo, K; Urushihata, K; Yamamoto, H	1
Hwang, JH; Kang, S; Lim, MC; Park, SY; Seo, SS; Yoo, HJ	1
Kivivuori, SM; Nygaard, R	1
Atenafu, EG; Brandwein, JM; Gupta, V; Minden, MD; Murray, C; Nixon, S; Saini, L; Schimmer, AD; Schuh, AC; Yee, KW	1
Bi, N; Cao, J; Li, J; Li, W; Liang, J; Lv, J; Ou, G; Ren, H; Wang, L; Wu, S; Zhang, X; Zhou, Z	1
Bartolesi, AM; Fanci, R; Pecile, P; Pini, G	1
Fukushima, N; Hasegawa, Y; Hashimoto, C; Hyo, R; Ishida, F; Isobe, Y; Ito, Y; Izutsu, K; Kawa, K; Kimura, H; Kobayashi, H; Maeda, Y; Nakamura, S; Okamura, S; Oshimi, K; Suzuki, R; Suzumiya, J; Takizawa, J; Yamaguchi, M	1
Ando, M; Gemma, A; Hino, M; Kobayashi, K; Kosaihira, S; Minegishi, Y; Miyanaga, A; Mizutani, H; Nomura, K; Noro, R; Okano, T; Seike, M; Yoshimura, A	1
Advani, R; Bartlett, NL; Blum, KA; Cheson, BD; Connors, JM; Fisher, RI; Friedberg, JW; Gascoyne, RD; Gordon, LI; Gospodarowicz, M; Habermann, TM; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Stiff, PJ; Tuscano, JM; Wagner, H	1
Fux-Arnold, C; Gavillet, M; Medinger, M; Tichelli, A	1
Ansari, RH; Atkins, JN; Bogart, JA; Green, MR; Hodgson, LD; Kelley, MJ; Pang, H; Vokes, EE	1
Ito, K; Kaiho-Sakuma, M; Kurosawa, H; Nagai, T; Nagase, S; Niikura, H; Otsuki, T; Takano, T; Tanaka, S; Tokunaga, H; Toyoshima, M; Utsunomiya, H; Yaegashi, N; Yoshinaga, K	1
Aulitzky, W; Bodenstein, H; Clemens, M; Ehninger, G; Illmer, T; Neubauer, A; Repp, R; Schaich, M; Schäkel, U; Soucek, S; Wandt, H	1
Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K	1
Bunin, N; Stern, JW	1
Chak, K; Chan, AT; Johnson, P; Lee, TW; Leung, TW; Mok, TS; Wong, H; Yeo, W; Yim, A; Yu, KH; Zee, B	1
Agelidou, M; Ferdoutsis, E; Georgoulias, V; Kalbakis, K; Kouroussis, Ch; Magkanas, E; Mavroudis, D; Samonis, G; Souglakos, J; Toumbis, M; Tselepatiotis, E; Tzanakis, N; Veslemes, M; Ziotopoulos, P	1
Connors, JM; Gascoyne, R; Klasa, RJ; Macpherson, N; O'Reilly, SE; Voss, N	1
Aledo, A; Alonzo, TA; Buxton, AB; Kobrinsky, NL; Lange, BJ; Woods, WG	1
Crump, M; Emmanouilides, C; Flinn, I; Frankel, S; Hackett, J; Lazarus, H; Liang, BC; Lovelace, W; Moore, J; Schenkein, D; Vose, JM	1
Eguchi, K; Goto, K; Hojo, F; Kakinuma, R; Kodama, T; Kubota, K; Kunitoh, H; Matsumoto, T; Nishiwaki, Y; Ohe, Y; Ohmatsu, H; Saijo, N; Sekine, I; Shinkai, T; Tamura, T; Yoshimura, K	1
Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B	1
Okamoto, Y; Pui, CH; Razzouk, BI; Ribeiro, RC; Shenep, JL; Srivastava, DK	1
Au, WY; Chan, EC; Kwong, YL; Leung, AY; Liang, R; Lie, AK; Ooi, GC; Siu, LL	1
Bar-Sela, G; Gaitini, D; Haim, N; Steiner, M; Tsalic, M	1
Ahn, YC; Im, YH; Jung, CW; Kang, WK; Kim, H; Kim, K; Lee, KE; Lee, MH; Lee, SH; Lim, DH; Park, J; Park, K; Park, SH	1
Creutzig, U; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Reinhardt, D; Varwig, D	1
Butts, JA; Greco, FA; Hainsworth, JD; Meluch, AA; Morrissey, LH; Raefsky, EL; Steis, RG	1
Blijlevens, N; de Pauw, B; Donnelly, P; Levenga, H; Shirango, H; Verweij, P	1
Filippa, DA; Gencarelli, A; Kewalramani, T; Moskowitz, CH; Nimer, SD; Noy, A; O'Connor, O; Portlock, C; Qin, J; Straus, D; Teruya-Feldstein, J; Waxman, A; Yahalom, J; Zelenetz, AD	1
Anthoney, DA; Graham, J; Hutcheon, AW; Jones, W; Kaye, SB; McKean, MJ; Paul, J; Roberts, JT	1
Amodeo, R; Anghel, G; De Rosa, L; Majolino, I; Pandolfi, A; Riccardi, M	1
Aström, M; Björkholm, M; Hast, R; Hedenius, M; Lerner, R; Liliemark, J; Löfgren, C; Nilsson, I; Paul, C; Rödjer, S; Simonsson, B; Stockelberg, D; Tidefelt, U	1
Beganovic, S; Niell, HB; Richey, S; Wan, JY	1
Bower, M; Davies, L; Gazzard, B; Gupta, S; McCall-Peat, N; Nelson, M; Ryan, N; Stebbing, J; Young, AM	1
Goto, K; Kakinuma, R; Kodama, T; Kubota, K; Kunitoh, H; Matsui, K; Matsumoto, T; Niho, S; Nishiwaki, Y; Nokihara, H; Ohe, Y; Ohmatsu, H; Saijo, N; Sekine, I; Shinkai, T; Sugiura, T; Tamura, T; Yamamoto, N; Yoshida, K	1
Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, XB; Pan, ZH; Peng, YL; Wang, W; Xia, ZJ	1
Crowley, JJ; Dakhil, SR; Edelman, MJ; Gandara, DR; Gaspar, LE; Le, QT; McCoy, J; Ryu, J; Sides, SD; Williamson, S	1
Billmire, DF; Cullen, JW; Cushing, B; Davis, MM; Giller, RH; Lauer, SJ; London, WB; Marina, N; Olson, TA; Rescorla, F; Rogers, PC	1
Alessandrino, EP; Banfi, L; Barbarano, L; Cairoli, R; Corso, A; De Paoli, A; Fava, S; Ferrari, D; Fiumanò, M; Frigerio, G; Isa, L; Klersy, C; Lazzarino, M; Luraschi, A; Mangiacavalli, S; Morra, E; Perego, D; Pinotti, G; Savarè, M; Ucci, G; Uziel, L; Vergani, C; Vismara, A; Zappasodi, P	1
Chott, A; Drach, J; Hejna, M; Hoffmann, M; Püspök, A; Raderer, M; Wöhrer, S	1
Bergeron, C; Bernard, F; Boneu, A; Bouzy, J; Chastagner, P; Coze, C; Hartmann, O; Michon, J; Perel, Y; Plantaz, D; Rodary, C; Rubie, H; Valteau-Couanet, D	1
Fujino, H; Hayashi, K; Hirai, M; Hirose, A; Ishii, K; Katsurada, T; Kitajima, H; Kitayama, H; Mugitani, A; Ohta, T; Shigeki, T; Teshima, H; Urase, F; Yagi, T; Yamamoto, Y	1
Blayney, DW; Cruickshank, SE; Johnson, DH; McGuire, BW	1
Bower, M; Powles, T; Stebbing, J; Thirlwell, C	1
Dong, M; Feng, FY; He, XH; Huang, DZ; Liu, P; Shi, YK; Yang, JL; Yang, S; Zhang, CG; Zhang, P; Zhou, SY	1
Ashcroft, LF; Lorigan, P; O'Brien, ME; Sampson, MR; Thatcher, N; Woll, PJ	1
Buchholz, E; Gatzemeier, U; Goetz, E; Groth, G; Manegold, C; Reck, M	1
Hofland, KF; Jensen, PB; Sehested, M; Thougaard, AV	1
Abali, H; Barista, I; Demirkazik, F; Kansu, E; Kars, A; Koc, Y; Oyan, B; Tekin, F; Tekuzman, G; Turker, A; Uner, A	1
Balis, F; Bates, S; Cole, D; Egorin, MJ; Flynn, BM; Fojo, T; Knutsen, T; Langham, G; Rao, VK; Ried, T; Steinberg, SM; Wangsa, D	1
Bazari, H; Forman, JP; Humphreys, BD; Magee, CC; Seifter, J; Zandi-Nejad, K	1
Decatris, MP; O'Byrne, KJ; Sundar, S	1
Aimé, P; Coninx, P; Legros, M; Mérol, JC; Moutel, K; Nasca, S; Prévost, A; Roger-Liautaud, F	1
Błoński, JZ; Chojnowski, K; Kasznicki, M; Robak, T; Szmigielska-Kapłon, A	1
Chamorey, E; Delwail, V; Fabbro, M; Foussard, C; Gressin, R; Harrousseau, JL; Lepeu, G; Maisonneuve, H; Peyrade, F; Richard, B; Rossi, JF; Thyss, A; Vilque, JP	1
De Silva, CR; Lansigan, E; Locke, R; Negassa, A; Sparano, JA; Wiernik, PH	1
Alberts, SR; Erlichman, C; Furth, A; Lathia, CD; Molina, JR; Reid, JM; Safgren, SL; Sloan, JA	1
Astori, C; Bonfichi, M; Cafro, AM; Castagnola, C; Corso, A; Lazzarino, M; Mangiacavalli, S; Morra, E; Nosari, A; Pascutto, C; Rusconi, C; Troletti, D; Varettoni, M; Zappasodi, P	1
Arnaiz Fernández, MD; Cardenal Alemany, F; Guedea Edo, F; Jeremic, B; Lucas Calduch, A; Montes Borinaga, A; Navarro Pérez, V; San José Maderuelo, S; Serrano Bermúdez, G	1
Bunn, P; Kelly, K; Magree, L; Rabinovitch, R; Sunpaweravong, P	1
Adang, EM; Akkermans, J; Biesma, B; Bootsma, GP; Cheragwandi, SA; de Boo, TM; Hensing, CA; Smit, HJ; Termeer, A; Timmer-Bonte, JN; Tjan-Heijnen, VC; Wilschut, FA	1
Bagatell, R; Bowman, LC; Brodeur, GM; Castleberry, R; Cohn, SL; Frantz, C; Joshi, V; London, WB; Look, AT; Rao, PV; Rumcheva, P; Thorner, P	1
Cai, QQ; Guan, ZZ; Huang, HQ; Jiang, WQ; Lin, TY; Lin, XB; Pan, ZH; Peng, YL; Xia, YF; Xia, ZJ	1
Doi, S; Fukuda, M; Kasai, T; Kawabata, S; Kinoshita, A; Kohno, S; Nagashima, S; Oka, M; Soda, H; Soejima, Y; Takatani, H	1
Atkins, H; Bence-Bruckler, I; Bredeson, C; Huebsch, L; Leger, C; McDiarmid, S; Sabloff, M; Zhang, H	1
Aoki, S; Hirano, M; Kohori, M; Miura, I; Niitsu, N; Okamoto, M	1
Chatelut, E; Henningsson, A; Karlsson, MO; Kloft, C; Wallin, J	1
Ashley, S; Banerji, U; Benepal, T; Coward, J; Eisen, T; Hughes, S; Norton, A; O'Brien, M; Zee, Y	1
Ando, M; Eguchi, K; Fukuoka, M; Ichinose, Y; Kudoh, S; Matsui, K; Nakagawa, K; Negoro, S; Saito, H; Tada, T; Takada, M; Takada, Y; Tamura, K	1
Chen, ZP; Mu, YG; Sai, K; Shi, HL; Yue, WY; Zhang, JP; Zhang, XH	1
Su, Y	1
Desai, AA; Fleming, GF; House, L; Innocenti, F; Kobayashi, K; Ramirez, J; Ratain, MJ; Schilsky, RL; Shepard, D; Vogelzang, NJ; Yong, WP	1
Bishton, MJ; Byrne, JL; Haynes, AP; Lush, RJ; Russell, NH; Shaw, BE	1
Ebeling, P; Metz, K; Moritz, T; Müller, S; Nowrousian, MR; Passon, J; Schütt, P; Seeber, S; Welt, A	1
Aydiner, A; Camlica, H; Derin, D; Guney, N; Tas, F; Topuz, E	1
Harita, S; Hotta, K; Kiura, K; Kuyama, S; Okimoto, N; Segawa, Y; Shinkai, T; Tabata, M; Tanimoto, M; Ueoka, H; Yonei, T	1
Yoneda, S	1
Awan, F; Devine, S; Hamadani, M	1
Akutsu, M; Inoue, K; Izumi, T; Kano, Y; Katano, S; Kobayashi, H; Masuda, Y; Muroi, K; Nagashima, T; Ohmine, K; Ozawa, K; Shirai, T; Takagi, S; Tsunoda, S; Ueda, M; Ueda, T	1
Bogdanova, E; Gregory, SA; Harting, R; O'brien, T; Venugopal, P	1
Saitou, K; Saitou, Y; Suzuki, S; Uzuka, Y; Yamaguchi, M	1
Astori, C; Bonfichi, M; Ciapanna, D; Corso, A; Lazzarino, M; Mangiacavalli, S; Morra, E; Nosari, AM; Varettoni, M; Zappasodi, P	1
Aversa, SML; Bianco, A; Errante, D; Salvagno, L	1
Greco, FA; Hainsworth, JD; Johnson, DH; Wolff, SN	1
Booser, DJ; Carr, DT; Chiuten, DF; Dhingra, HM; Farha, P; Issell, BF; Murphy, WK; Spitzer, G; Umsawasdi, T; Valdivieso, M	1
Barkley, HT; Benjamin, RS; Bodey, GP; Ertel, M; Freeman, MB; Mountain, CF; Smith, TL; Valdivieso, M	1
Bodey, GP; Cabanillas, F; Freireich, EJ; Hagemeister, FB	1
Akard, L; Chang, Q; English, D; Hanks, S; Harvey, K; Jansen, J; Thompson, J	1
Akbulut, H; Arican, A; Cay, F; Demirkazik, A; Dinçol, D; Içli, F; Karaoğuz, H	1
Bugat, R; Canal, P; Chatelut, E; Chevreau, C; De Fenin, V; Houin, G; Lavit, M; Lochon, I	1
Anglin, P; Brandwein, JM; Strauss, BA	1
Bender, JG; Coon, J; George, S; Ghalie, R; Kaizer, H; Lee, W; Lum, L; McLeod, B; Unverzagt, KL; Van Epps, D	1
Ciaccia, D; Corey, GR; Peters, W; Thel, MC; Vredenburgh, JJ	1
Newlands, ES; O'Reilly, SM; Rustin, GJ; Smith, DB	1
Angus, B; Carey, P; Evans, RG; Jackson, GH; Lennard, AL; Lucraft, H; Proctor, SJ; Taylor, PR	1
Cerny, T; Fey, M; Honegger, H; Jacky, E; Jost, LM; Pichert, G; Platzer, E; Stahel, RA; Tobler, A	1
de Haan, G; Dontje, B; Engel, C; Loeffler, M; Nijhof, W	1
Acolet, D; Deane, M; Murray, NA; Price, J; Roberts, IA	1
Begley, CG; Boyd, AW; Grigg, AP; Lickliter, JD; Szer, J	1
Bildet, F; Cour-Chabernaud, V; Hodgetts, J; Lomax, L; Thatcher, N; Woll, PJ	1
Bertini, M; Botto, B; Freilone, R; Gavarotti, P; Levis, A; Orlandi, E; Orsucci, L; Pini, M; Pizzuti, M; Vitolo, U	1
Cooper, DL; Flynn, SD; Reale, MA; Strair, RK; Yen, Y	1
Anderson, H; Bleehen, NM; Girling, DJ; Lallemand, G; Machin, D; Stephens, RJ; Thatcher, N	1
Saeter, G; Solheim, OP; Talle, K	1
Dranitsaris, G; Sutcliffe, SB	1
Fujimoto, N; Higuchi, M; Kawamura, M; Kuni-Eda, Y; Kurosawa, M; Maekawa, I; Morioka, M; Ohmura, T; Okabe, M; Suzuki, S	1
Green, MR; Lilenbaum, RC; MacManus, DA	1
Feng, FY; Shi, YK; Sun, Y	1
Crawford, J; George, M	1
Carey, RW; Elias, AD; Grossbard, ML; Jacobs, C; Jauss, S; Kwiatkowski, DJ; Lynch, TJ; Shulman, LN; Strauss, GM; Sugarbaker, DJ	1
Bezwoda, WR; Dansey, RD; Seymour, L	1
Griffin, JP; Miller, AA; Niell, HB	1
Beasley, K; Bunn, PA; Crowley, J; Gandara, DR; Hazuka, MB; Hicks, WJ; Kelly, K; Livingston, R; Upchurch, C; Weiss, GR	1
Cairo, MS	1
Greco, FA; Hainsworth, JD; Stroup, SL	1
Douglass, EC; Gajjar, AJ; Greenwald, C; Heideman, RL; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JA; Li, Y; Walter, AW	1
Albeck, M; Bruderman, I; Catane, R; Kalechman, Y; Kaufman, B; Shani, A; Shapira, J; Sredni, B; Tichler, T	1
Watkins, SM	1
Bates, S; Bryant, G; Cheson, BD; Fojo, A; Herdt, J; Jaffe, ES; Kohler, DR; Steinberg, SM; Wilson, WH; Wittes, RE	1
Decoster, G; Depierre, A; Gatzemeier, U; Green, J; Johnson, P; Lebeau, B; Manegold, C; Tomita, D; Trillet-Lenoir, V; Von Pawel, J	1
Ballestrero, A; Basta, P; Brema, F; Ferrando, F; Ghio, R; Gobbi, M; Moraglio, L; Patrone, F; Sessarego, M; Valbonesi, M	1
Smith, DC; Trump, DL	1
Goldstone, AH; Khwaja, A; Linch, DC	1
Cavalli, F; Cerny, T; De Fusco, M; De Jong, J; Gentili, D; McDaniel, C; Pagani, O; Prins, C; Sessa, C; Zucchetti, M	1
Bajorin, DF; Bokemeyer, C; Bosl, GJ; Demetri, GD; Einhorn, LH; Kantoff, PW; Nichols, CR; Schmoll, HJ	1
Shi, YK; Su, M; Sun, Y	1
Cuffie, C; Fisher, RI; Hamm, J; Kaiser, G; Oken, M; Schiller, JH; Shepherd, F	1
Bajorin, DF; Bosl, GJ	1
Bowman, LC; Douglass, EC; Furman, WL; Hudson, M; Marina, NM; Meyer, WH; Pappo, A; Rodman, J; Santana, VM; Shema, SJ	1
Abdel-Warith, A; Berry, J; Ezzat, AA; Khalifa, F; Khan, B; Raja, MA	1
Allen, SL; Behr, J; Budman, DR; Hock, K; Igwemezie, LN; Kaul, S; Kolitz, J; Lichtman, S; Schulman, P; Vinciguerra, V	1
Crown, JP; Hamilton, N; Heelan, RT; Heller, G; Kritz, A; Moore, MP; Motzer, RJ; Reich, LM; Schneider, JG; Yao, TJ	1
Davidson, A; Lewis, I; Pearson, AD; Pinkerton, CR; Stevens, MC	1
Benz, G; Gmür, J; Gubler, J	1
Greco, FA; Hainsworth, JD; Johnson, DH; Lamar, RE; Murphy, PB	1
Schein, M; Wohl, I	1
Comis, R; Haas, N; Kilpatrick, D; Krigel, RL; Langer, C; Padavic, K; Palackdharry, CS	1
Boutan-Laroze, A; Chazard, M; Culine, S; Droz, JP; Kattan, J; Kramar, A; Mahjoubi, M	1
Advani, SH; Iyer, RS; Kurkure, PA; Nair, CN; Pai, SK; Rao, SR	1
Bowen, KJ; Burris, HA; Clark, GM; Eckardt, JR; Fields, SM; Kuhn, JG; Rinaldi, DA; Shaffer, DW; Smith, LS; Weiss, GR	1
Ferguson, J; Holdsworth, MT; Martinez, L; Neidhart, JA; Roon, R; Stidley, CA	1
Beyer, J; Bokemeyer, C; Illiger, HJ; Kneba, M; Kynast, B; Metzner, B; Ostermann, H; Poliwoda, H; Räth, U; Schmoll, HJ	1
Bell, B; Bernstein, ML; Buchanan, GR; Devine, S; Dreyer, Z; Grier, H; Krischer, J; Kung, F; Land, V; Whitehead, VM	1
Cavalli, F; Colombo, N; D'Incalci, M; Mangioni, C; Marzola, M; Pagani, O; Sessa, C; Zucchetti, M	1
Kueh, YK; Ong, ST	1
Chen, SC; Curtin, J; Groshen, S; Jeffers, S; Morrow, CP; Muggia, FM; Russell, C; Schlaerth, J	1
Alerci, M; Cavalli, F; D'Incalci, M; deJong, J; Gentili, D; Martinelli, G; Pagani, O; Sessa, C; Torri, V; Zucchetti, M	1
Alcaraz, J; Andrews, P; Braly, P; Goel, R; Gorelick, S; Hoff, S; Kim, S; Kirmani, S; McClay, EF; Plaxe, S	1
McKendrick, JJ; Mead, GM; Sweetenham, JW; Whitehouse, JM	1
Bowman, LC; Douglass, E; Furman, W; Hudson, M; Marina, NM; Meyer, W; Rodman, J; Santana, VM; Shema, SJ; Wilimas, J	1
Ansell, SM; Falkson, G	1
Berman, E; Golde, DW; Maslak, PG; Scheinberg, DA; Tyson, D; Weiss, MA; Yao, TJ	1
Dann, EJ; Gillis, S; Rund, D	1
Anderson, H; Clark, PI; Girling, DJ; Jenkins, B; Lallemand, G; Machin, D; Smith, DB; Stephens, RJ; Thatcher, N	1
Haynes, FA; Holcenberg, J; Mayernik, DG; Neidhart, JA; Nemunaitis, J; Oette, DH; Quick, DP; Triozzi, P; Verma, S; Yau, JC	1
Hirokawa, M; Lee, M; Miura, AB; Motegi, M	1
Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K	1
Chau, WK; Chiu, CF; Ho, CH; Hsu, HC; Tan, TD; Tseng, CS	1
Bromberg, C; Chmura, M; DeConti, RC; Harper, GR; Healey, B; Hilstro, J; Horton, J; Remick, SC; Ruckdeschel, JC; Sporn, J	1
Ball, ED; Bloom, EJ; deMagalhaes-Silverman, M; Lembersky, B; Lister, J; Pincus, SM; Rybka, WB; Voloshin, M; Wilson, J	1
Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Jaffe, E; Magrath, I; Neely, J; Nieder, M; Seibel, N; Shad, A; Venzon, D; Wittes, RA	1
Perry, MC; Rapp, JS; Rotche, RM	1
Dover, JS; Lee, PK	1
Bender, JG; Blake, M; Carreon, J; Lee, WJ; Oldham, F; Schilling, M; Smith, S; Swinney, P; Van Epps, D; Williams, DE; Williams, SF; Zimmerman, T	1
Bairey, O; Blickstein, D; Hadar, H; Lahav, M; Prokocimer, M; Shaklai, M; Shaklai, S; Sulkes, J	1
Eguchi, K; Fakuda, M; Kasai, T; Kurata, T; Ohe, Y; Oshita, F; Saijo, N; Shinkai, T; Tamura, T; Yamamoto, N	1
DeAngelis, LM; O'Brien, JP; Portlock, CS; Wong, ET	1
Bergmann, L; Hoelzer, D; Karakas, T; Knuth, A; Lautenschläger, G; Mitrou, PS	1
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L	1
Arbuck, SG; DeMaria, D; Ford, PA; Miller, LL; Minniti, C; O'Dwyer, PJ	1
DeVore, R; Glick, J; Hutson, P; Johnson, D; Kim, K; Schiller, JH; Stewart, J	1
Benhamou, E; Bonnay, M; Couanet, D; Hartmann, O; Plantaz, D; Pondarré, C; Valteau-Couanet, D; Vassal, G	1
Anderson, N; Bern, M; Coco, F; Dow, E; Lokich, J; Moore, C	1
Avila, N; Balis, FM; DeLaney, TF; Hijazi, YM; Horowitz, ME; Jacobson, J; Jarosinski, P; Steinberg, SM; Tsokos, M; Weaver-McClure, L; Wexler, LH	1
Arpin, D; Bohas, C; Cordier, JF; Court-Fortune, I; Ecochard, D; Perol, M; Riou, R; Soler, P; Trillet-Lenoir, V	1
DeMoor, C; Eckardt, JR; Rinaldi, DA; Rodriguez, GI; Shaffer, DW; Stephens, C; Von Hoff, DD; Weiss, GR	1
Agaliotis, DP; Ballester, OF; Elfenbein, GJ; Fields, KK; Goldstein, SC; Hiemenz, JW; Janssen, WE; Perkins, JB; Zorksy, PE	1
Bianco, AR; Curcio, C; D'Aprile, M; Gebbia, V; Gridelli, C; Palmeri, S; Pepe, R; Pistillucci, G; Rossi, A; Veltri, E	1
Fanning, J; Hilgers, RD	1
Belli, M; Bianco, A; Cioffi, R; Comella, G; Comella, P; Curcio, C; De Cataldis, G; Della Vittoria, M; Frasci, G; Ianniello, G; Maiorino, L; Panza, N; Perchard, J	1
Delgado, FG; Garin, AM; Ljubimova, NV; Molchanov, GV; Sidorova, NJ; Sokolov, AV; Stenina, MB; Tjulandin, SA	1
Bunn, PA; Kelly, K	1
Bunn, PA	2
Amigo, ML; Caballero, MD; del Cañizo, C; García, R; Gonzalez, M; Hernández, JM; San Miguel, JF; Vazquez, L	1
Avanzini, P; Baldini, L; Cavanna, L; Colombi, M; Federico, M; Gobbi, P; Guffanti, A; Maiolo, AT; Pieresca, C; Silingardi, V	1
Ballester, OF; Elfenbein, GJ; Fields, KK; Goldstein, SC; Hiemenz, JW; Kronish, L; Moscinski, LC; Saba, HI; Spiers, AS; Sullivan, P; Zorsky, PE	1
Brodsky, AL; Melero, MJ; Minissale, CJ; Sánchez Avalos, JC	1
Katschinski, DM; Mentzel, M; Mulkerin, DL; Robins, HI; Touhidi, R; Wiedemann, GJ	1
Chen, YM; Chou, CM; Lin, WC; Liu, JM; Perng, RP; Tsai, CM; Whang-Peng, J; Wu, MF; Yang, KY	1
Falkowski, S; Romejko-Jarosińska, J; Siedlecki, P; Walewski, J; Zwoliński, J	1
Betts, E; Goebel, ME; Honegger, H; Jost, LM; Nagler, A; Stahel, RA	1
Di Leone, L; Gerhardt, L; Kalakun, L; Kromfield, M; Mans, DR; Prolla, G; Sander, E; Schwartsmann, G; Sprinz, E	1
Carpenter, P; Lockwood, L; McCowage, GB; Shaw, PJ; Tiedemann, K; Toogood, I; White, L	1
Arango, HA; Decesare, SL; Fiorica, JV; Kalter, CS; Lyman, GH; Spellacy, WN	1
Gandara, DR; Lau, DH; Rosenthal, SA; Ryu, JK	1
Colleoni, M; Graiff, C; Manente, P; Nelli, P; Pancheri, F; Sgarbossa, G; Vicario, G	1
Fukuoka, M; Furuse, K; Masuda, N; Negoro, S; Saijo, N	1
Buhles, W; Hersh, E; Issell, B; Neidhart, J; Rinehart, J; Triozzi, P	1
Camoriano, JK; Fitch, TR; Frytak, S; Rajkumar, SV; Rubin, J	1
Beck, D; Béhar, C; Bergeron, C; Bernard, JL; Bordigoni, P; Coze, C; Dusol, F; Frappaz, D; Hartmann, O; Leverger, G; Mechinaud, F; Michon, J; Otten, J; Philip, T; Plantaz, D; Plouvier, E; Rubie, H; Zucker, JM	1
Fazeny, B; Fridrik, MA; Greil, R; Hausmaninger, H; Helm, W; Hudec, M; Klocker, J; Krieger, O; Neubauer, M; Oppitz, P; Pont, J; Radaszkiewicz, T; Simonitsch, I; Stöger, M	1
Fisher, C; Harmer, CL; Judson, IR; Thomas, JM; Verrill, MW; Wiltshaw, E	1
Armstrong, S; Crawford, J; Dziem, G; Garewal, H; Jones, SE; Kreisman, H; Pupa, MR; Shoemaker, D; Tomita, D	1
Allen, J; Bayer, L; Dunkel, IJ; Finlay, JL; Gardner, S; Garvin, J; Grovas, A; Halpern, S; Heller, G; Lindsley, K; Lyden, D; Mason, WP; Merchant, TE; O'Malley, B; Petriccione, MM; Puccetti, D; Rosenblum, M; Sands, S	1
Arnold, B; Furman, WL; Garrison, L; Hanna, R; Luo, X; Marina, N; Meyer, WH; Pratt, CB; Rodman, JH; Tonda, ME	1
Fossella, F; Glisson, B; Hong, WK; Lee, JS; Murphy, WK; Palmer, J; Perez-Soler, R; Shin, DM	1
Fossella, F; Glisson, B; Komaki, R; Kurie, J; Lee, JS; Murphy, WK; Perez-Soler, R; Schea, R; Shin, DM; Vadhan-Raj, S	1
Minami, H; Saka, H; Sakai, S; Shimokata, K; Yamamoto, M	1
Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M	1
Chan, HS; Doyle, J; Greenberg, ML; Karaskov, V; Koren, G; Malkin, D; Moncica, I; Theis, JG	2
Altaras, M; Beyth, Y; Chowers, M; Fishman, A; Lang, R	1
Bouffet, E; Desjardins, L; Doz, F; Gentet, JC; Lutz, P; Michon, J; Namouni, F; Neuenschwander, S; Pacquement, H; Plantaz, D; Quintana, E; Tanguy, ML; Validire, P; Vannier, JP; Zucker, JM	1
Ariyoshi, Y; Fukuoka, M; Furuse, K; Kurita, Y; Nishiwaki, Y; Noda, K; Saijo, N; Tamura, T; Watanabe, K	1
Miller, AA; Niell, HB; Tolley, EA	1
Anderson, N; Bern, M; Coco, F; Dow, E; Gotthardt, S; Lokich, J; Oliynyk, P	1
Alessandrino, EP; Bernasconi, C; Bernasconi, P; Bonfichi, M; Brusamolino, E; Canevari, A; Castagnola, C; Castelli, G; Lazzarino, M; Pagnucco, G	1
Crawford, J; Graziano, SL; Herndon, JE; Mehdi, SA; Perry, MC; Young, R	1
Braess, J; Büchner, T; Fuchs, R; Grote-Metke, A; Hiddemann, W; Hossfeld, DK; Kern, W; Kuse, H; Reichle, A; Wörmann, B	1
Akaza, H; Iida, K; Imada, S; Kawai, K; Miyanaga, N; Tsukamoto, S	1
Cox, JD; Fossella, FV; Glisson, BS; Hong, WK; Komaki, R; Lee, JS	1
Benjamin, RS; Gano, J; Gianan, MA; Jaffe, N; Jia, SF; Kleinerman, ES; Papadopoulos, NE; Patel, S; Raymond, AK; Rodriguez, C; Worth, LL	1
Bernstein, SH; Christiansen, NP; Fay, JP; Herzig, GP; Pinero, L; Shah, D; Stephan, M	1
D'Incalci, M; De Fusco, M; de Jong, J; Gentili, D; Martinelli, G; Pagani, O; Sessa, C; Tinazzi, A; Torri, V; Zucchetti, M	1
Bigazzi, C; Bocchia, M; Forconi, F; Lauria, F; Marotta, G	1
Fujii, S; Hasegawa, K; Hirabayasi, K; Ikeda, M; Izumi, R; Kono, I; Kudo, R; Niitani, H; Nishiya, I; Noda, K; Ochiai, K; Ogita, Y; Okada, H; Ozaki, M; Saito, T; Sugimori, H; Suzuoki, Y; Tanaka, K; Terashima, Y; Tomoda, Y; Umesaki, N; Yajima, A; Yakushiji, M; Yamabe, T; Yamamoto, T	1
Bernard, JL; Bordigoni, P; Bouffet, E; Cattiaux, E; Coze, C; Hartmann, O; Lemerle, J; Meresse, V; Michon, JM; Philip, T; Rubie, H; Ward, N; Zucker, JM	1
Haga, N; Honda, K; Itoh, M; Muraki, O; Ohto, H; Tsuruya, Y; Yamaguchi, O	1
Lehman, S; Löfgren, C; Möllgård, L; Paul, C; Sundman-Engberg, B; Tidefelt, U	1
Armand, JP; Couteau, C	1
Anton, A; Barneto, I; Font, A; Garcia-Giron, C; Moyano, AJ; Puerto, JM; Rosell, R; Salvador, A; Sanchez, JJ; Tres, A	1
Bramwell, V; Rusthoven, J; Stephenson, B	1
Camera, A; Catalano, L; Picardi, M; Rotoli, B; Selleri, C	1
Altés, A; Brunet, S; Guardia, R; Martino, R; Sierra, J; Sureda, A	1
Auer, I; Brown, C; Chaudhry, A; Guo, D; Jones, AR; Klassen, J; Luider, J; Morris, D; Poon, MC; Ruether, BA; Russell, JA; Stewart, DA	1
Eady, A; Evans, WK; Gagliardi, A; Kocha, W; Newman, TE	1
Brunet, S; Martino, R; Muñoz, L; Sierra, J; Subirà, M; Sureda, A	1
Bréchot, JM; Chastang, C; L'Her, P; Lebas, FX; Lebeau, B; Leclerc, P; Meekel, P; Paillotin, D; Urban, T; Vincent, J	1
Fossella, FV; Fox, NJ; Glisson, BS; Hong, WK; Kurie, JM; Lee, JS; Murphy, WK; Nyberg, DA; Perez-Soler, R; Pisters, KM; Ross, MB; Shin, DM	1
Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P	1
Bunn, PA; Kelly, K; Murphy, J; Pan, Z; Wood, ME	1
Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P	1
Conrad, EU; Felgenhauer, J; Hawkins, D; Lindsley, K; Miser, JS; Pendergrass, T	1
Ozbek, N; Tuncer, AM; Yetgin, S	1
Girling, DJ; Hopwood, P; Qian, W; Sambrook, RJ; Stephens, RJ; Thatcher, N	1
Abgrall, JF; Audhuy, B; Casassus, P; Deconinck, E; Delain, M; Desablens, B; Guilhot, F; Guyotat, D; Harousseau, JL; Hunault-Berger, M; Le Prise, PY; Lioure, B; Solary, E; Tournilhac, O; Vilque, JP; Witz, B	1
Gregora, E; Havrdová, E; Kobylka, P; Kozák, T; Maaloufová, J; Marecková, H; Pit'ha, J; Pytlík, R; Vodvárková, S	1
Auclerc, MF; Auvrignon, A; Baruchel, A; Bauduer, F; Berthou, C; Bordigoni, P; Demeocq, F; Lamagnere, JP; Landman-Parker, J; Leblanc, T; Legall, E; Leverger, G; Mathey, C; Michel, G; Pautard, B; Perel, Y; Schaison, G; Schneider, P	1
Benz, MS; Kramer, D; Murray, TG; Scott, IU; Toledano, S	1
Berkowitz, R; Cannistra, SA; Kim, Y; Matulonis, U; Niloff, J; Quartulli, M; Seiden, M; Tung, N	1
Bilgrami, S; Bona, RD; Edwards, RL; Feingold, JM; Kapur, D; Khan, AM; Rodriguez-Pinero, F; Tutschka, PJ	1
Crawford, J; Glaspy, J; Mazanet, R; Ozer, H; Tomita, DK	1
Fernandez, MC; Gerbing, RR; Krailo, MD; Matthay, KK	1
Amoroso, D; Ballestrero, A; Boccardo, F; Ferrando, F; Garuti, A; Gonella, R; Patrone, F; Sessarego, M; Stura, P	1
Clowes, C; Duarte, R; Pu, QQ; Wang, X	2
Fowler, JM; Greer, BE; Horowitz, IR; McGuire, WP; Rodriguez, M; Rose, PG; Waggoner, S	1
Glisson, B; Komaki, R; Movsas, B; Scott, C; Wagner, H	1
Angus, B; Carey, PJ; Finney, RD; Galloway, MJ; Goff, DK; Haynes, A; Jackson, GH; Lennard, AL; Leonard, RC; McQuaker, IG; Proctor, SJ; Russell, N; Taylor, PR; Windebank, K	1
Cesaro, S; Chinello, P; Rossi, L; Zanesco, L	1
Cullen, MH; Dearnaley, DP; Fossa, SD; Harland, SJ; Horwich, A; Lallemand, E; Mead, GM; Oliver, RT; Roberts, JT; Stenning, SP; Wilkinson, PM	1
Brown, JM; Gurney, EM; Hepburn, PM; Johnson, PW; Muers, MF; Napp, VV; Peake, MD; Poulter, KM	1
Bauer, M; Blatt, J; Blazar, BR; Cairo, MS; Frierdich, S; Krailo, MD; Liu-Mares, W; Miser, JS; Reaman, GH; Sato, JK; Shen, V	1
Weiss, M	1
Bourg, V; Chichmanian, RM; Frenay, M; Lebrun, C; Thomas, P	1
Mazeron, JJ; Noël, G	1
Agelidou, M; Bania, E; Georgoulias, V; Jordanoglou, J; Kakolyris, S; Kouroussis, C; Mavroudis, D; Papadakis, E; Stavrakakis, J; Tsiafaki, X; Veslemes, M; Vlachonicolis, J	1
Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A	1
Berthold, F; Fichtner, I; Fulda, S; Hero, B	1
Bartlett, NL; Canellos, GP; Gockerman, JP; Johnson, JL; Omura, GA; Parker, BA; Peterson, BA; Petroni, GR; Robert, M; Wagner, ND	1
Bunn, PA; Crowley, JJ; Gandara, DR; Kelly, K; Livingston, RB; Lovato, L; Roychowdhury, D; Taylor, SA; Zangmeister, J	1
Fukuoka, M; Hirashima, T; Kobayashi, M; Masuda, N; Matsui, K; Nitta, T; Takada, Y; Yana, T	1
Ainslie, J; Hamilton, C; Harvey, J; Keller, J; Macintosh, J; Poulsen, M; Rischin, D; Tripcony, L; Walpole, E	1
Azinovic, I; Brugarolas, A; Fernández-Hidalgo, O; García-Rayo, S; Martín-Algarra, S; Martínez-Aguillo, M; Martínez-Monge, R; Pérez-Calvo, J; Rebollo, J; Subirá, L	1
Barcos, M; Bloomfield, CD; Freter, CE; Frizzera, G; Johnson, JL; Lee, EJ; Peterson, BA; Petroni, GR; Schiffer, CA	1
Briassoulis, E; Fountzilas, G; Kalofonos, HP; Kardamakis, D; Kosmidis, P; Kouvatseas, G; Panoussaki, E; Pavlidis, N; Samantas, E; Skarlos, DV; Tsavdaridis, D; Tsekeris, P; Tsiakopoulos, E; Tzitzikas, J; Zamboglou, N	1
Jain, VK; Ogden, JL; Wilder, DD	1
Bombaron, P; Dussopt, C; Fournel, P; Larive, S; Lecaer, H; Lena, H; Perol, M; Philip-Joet, F; Riou, R; Souquet, PJ; Touraine, F	1
Ardizzoni, A; Biesma, B; Buchholz, E; Burghouts, J; Debruyne, C; Gans, S; Giaccone, G; Legrand, C; Manegold, CH; Mollers, M; Postmus, PE; Tjan-Heijnen, VC; van Meerbeeck, J	1
Blystad, AK; Delabie, J; Holte, H; Kvalheim, G; Kvaløy, S; Smeland, E	1
Bernstein, M; Devidas, M; Ferguson, W; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, MB; Link, M; Schwartz, CL; Siegal, GP	1
Giaccone, G; Huisman, C; Postmus, PE; Smit, EF	1
Balis, F; Chabner, BA; Cheson, BD; Cole, D; Drbohlav, N; Grossbard, ML; Gutierrez, M; Harris, N; Jaffe, ES; Janik, J; Little, RF; Longo, DL; Pearson, D; Pittaluga, S; Raffeld, M; Staudt, L; Steinberg, SM; Wilson, WH; Wittes, R	1
Ardizzoni, A; Postmus, PE; Tjan-Heijnen, VC	1
Arnold, BA; Cain, AM; Crist, WM; Fairclough, D; Furman, WL; Meyer, WH; Pratt, CB	1
Evans, WK; Goss, PE; Latreille, J; Logan, D; Maroun, J; Paul, K; Shepherd, FA; Stewart, D; Warner, E	1
Bishop, JF; Kefford, RF; Matthews, JP; Morstyn, G; Raghavan, D; Stuart-Harris, R; Zalcberg, J	1
DeVore, R; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Thomas, M; Walls, J	1
Bentley, J; Crowther, D; Deakin, DP; Gurney, H; James, R; Kane, K; Pettengell, R; Radford, JA; Wilkinson, PM	1
Band, PR; Connors, JM; Fetherstonhaugh, EM; Goldie, JH; Knowling, MA; Osoba, D	1
Almadrones, L; Barakat, R; Curtin, J; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S	1
Green, MR; Mason, JR; Mullen, M; Newton, B; Shea, TC; Storniolo, AM; Taetle, R	1
Bowman, LC; Brenner, MK; Mirro, J; Santana, VM; Schell, MJ; Thompson, EI; Williams, R	1
Blundell, EL; Brown, NM; Chown, SR; Hill, JA; Slade, RR; Warnock, DW	1
Deisseroth, A; Dicke, K; Dunphy, F; Fogel, B; Huan, S; Jagannath, S; Souza, L; Spitzer, G; Taylor, K; Ventura, G	1
Hardy, JR; Pinkerton, CR	1
Cebon, J; Fox, R; Layton, J; Lieschke, G; Morstyn, G; Sheridan, W	1
Jost, LM; Pichert, G; Stahel, RA	1
Crawford, J; Grous, J; Johnson, D; Kris, M; Lyman, G; Ozer, H; Picozzi, V; Rausch, G; Stoller, R; Tabbara, I	1
Furukawa, H; Hara, T; Hoshino, K; Taniguchi, T	1
Hughes-Davies, LT; Murray, P; Spittle, M	1
Goldstone, A; McMillan, A	1
Bowman, LC; Douglass, EC; Evans, WE; Fairclough, DL; Furman, WL; Huhn, RD; Petros, WP; Pratt, CB; Santana, VM; Stute, N	1
Ball, D; Bishop, JF; Bull, C; Friedlander, M; Kefford, R; Olver, IN; Raghavan, D; Stuart-Harris, R; Yuen, K; Zalcberg, J	1
Ashley, SA; Ford, HT; Forgeson, GV; Perren, TJ; Smith, IE; Woodiwiss, J; Yarnold, JR	1
Evans, WK; Goss, PE; Latreille, J; Logan, D; Maroun, J; Shepherd, FA; Stewart, D; Warner, E	1
Arriagada, R; Daurès, JP; Douillard, JY; Dubois, JB; Godard, P; Le Chevalier, T; Mary, H; Pujol, JL; Rossi, JF; Rouanet, P	1
Pizzillo, MF; Salva, KM; Schwartz, EL; Sparano, JA; Wadler, S; Wiernik, PH	1
Briere, J; Casassus, P; Desablens, B; Gandhour, C; Harousseau, JL; Ifrah, N; Le Prise, PY; Milpied, N	1
Sparano, JA; Wiernik, PH	1
Longo, WL; McCroskey, RD; Mosher, DF; Prendergast, E; Spencer, CD	1
Clark, P; Costeloe, K; Raffles, A; Williams, J	1
Collins, C; Griffin, BR; Higano, CS; Keppen, MD; Livingston, RB; Miller, TP	1
Devereaux, S; Goldstone, AH; Gribben, JG; Linch, DC; McMillan, A; Patterson, K	1
Kaplan, LD; Volberding, PA	1
Figueredo, AT; Frank, G; Hryniuk, WM; Rendell, S; Strautmanis, I	1
Klastersky, J; Sculier, JP; Tueni, E	1
Ehninger, G; Freund, M; Heil, G; Hoelzer, D; Kurrle, E; Link, H; Mitrou, PS; Ohl, S; Queisser, W; Schlimok, G	1
Breatnach, F; Hartmann, O; Philip, T; Pinkerton, CR; Zucker, JM	1
Bowman, A; Chessells, JM; Holtzel, H; Pinkerton, CR	1
Armitage, JO; Cabanillas, FF; Dicke, KA; Horwitz, LJ; Jagannath, S; Spitzer, G; Vellekoop, L; Zander, AR	1

Reviews

17 review(s) available for etoposide and Neutropenia

Article	Year
Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis. European journal of cancer care, 2017, Volume: 26, Issue:6 Topics: Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Diarrhea; Etoposide; Fatigue; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Nausea; Neoplasm Staging; Neutropenia; Odds Ratio; Proportional Hazards Models; Small Cell Lung Carcinoma; Thrombocytopenia; Vomiting	2017
Rituximab-associated neutropenia. Seminars in hematology, 2010, Volume: 47, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Chemokine CXCL12; Cyclophosphamide; Doxorubicin; Etoposide; Granulocytes; Homeostasis; Humans; Incidence; Lymphoma, Non-Hodgkin; Neutropenia; Prednisone; Rituximab; Time Factors; Vincristine	2010
Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia. Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:9 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxyadenosines; Double-Blind Method; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Hypotension; Immunocompromised Host; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Retrospective Studies; Sepsis; Streptococcal Infections; Viridans Streptococci	2003
Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius--a pathogen or passenger? Annals of hematology, 2004, Volume: 83, Issue:7 Topics: Actinomycetales; Actinomycetales Infections; Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Translocation; Cefepime; Cephalosporins; Clostridium Infections; Colistin; Cytarabine; Daunorubicin; Drug Therapy, Combination; Etoposide; Fatal Outcome; Hemoptysis; Humans; Hydroxyurea; Immunocompromised Host; Intestinal Mucosa; Leukemia, Myeloid, Acute; Male; Metronidazole; Middle Aged; Neutropenia; Pneumonia, Bacterial; Superinfection; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination	2004
The impact of dose per cycle of etoposide and cisplatin on outcomes in patients with extensive small-cell lung cancer. Clinical lung cancer, 2004, Volume: 5, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Humans; Leukopenia; Lung Neoplasms; Neoplasm Staging; Neutropenia; Randomized Controlled Trials as Topic; Survival Analysis; Thrombocytopenia; Treatment Outcome	2004
The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Interleukin-6; Lung Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia	1995
The use of ifosfamide, carboplatin, and etoposide in children with solid tumors. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Neoplasms; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Wilms Tumor	1995
The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia; Treatment Outcome	1996
Management of chemotherapy in a pregnancy complicated by a large neuroblastoma. Obstetrics and gynecology, 1994, Volume: 84, Issue:4 Pt 2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Nausea; Neuroblastoma; Neutropenia; Ondansetron; Pregnancy; Pregnancy Complications, Neoplastic; Recombinant Proteins; Retroperitoneal Neoplasms; Vomiting	1994
[Irinotecan-containing combinations in solid tumors, except colonic carcinomas]. Bulletin du cancer, 1998, Volume: Spec No Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diarrhea; Docetaxel; Enzyme Inhibitors; Etoposide; Female; Genital Neoplasms, Female; Humans; Irinotecan; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasm Proteins; Neoplasms; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Topoisomerase I Inhibitors; Treatment Outcome	1998
The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group. Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC, 1999, Volume: 3, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase II as Topic; Confidence Intervals; Deoxycytidine; Dose-Response Relationship, Drug; Etoposide; Gemcitabine; Humans; Lung Neoplasms; Neoplasm Staging; Neutropenia; Odds Ratio; Randomized Controlled Trials as Topic; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome	1999
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone. Hematology/oncology clinics of North America, 2001, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine	2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine	2001
Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 35, Issue:1 Topics: Administration, Oral; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neutropenia; Survival Rate; Treatment Outcome	2002
Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors. Progress in clinical and biological research, 1990, Volume: 354B Topics: Antineoplastic Agents; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Neutropenia	1990
What is the value of autologous bone marrow transplantation in the treatment of relapsed or resistant Hodgkin's disease? Leukemia research, 1991, Volume: 15, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Drug Resistance; Etoposide; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Melphalan; Neutropenia; Pilot Projects; Randomized Controlled Trials as Topic; Registries; Time Factors; Transplantation, Autologous	1991
Treatment of AIDS and its attendant malignancies. Progress in clinical and biological research, 1989, Volume: 288 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease Susceptibility; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Sarcoma, Kaposi; Vinblastine; Vincristine; Zidovudine	1989

Trials

222 trial(s) available for etoposide and Neutropenia

Article	Year
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome. Blood, 2022, 02-03, Volume: 139, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; Sulfonamides; Vincristine	2022
Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial. American journal of hematology, 2022, Volume: 97, Issue:5 Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Neutropenia; Prednisone; Thalidomide; Treatment Outcome	2022
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399. The oncologist, 2023, Nov-02, Volume: 28, Issue:11 Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Neutropenia; Small Cell Lung Carcinoma; Thrombocytopenia	2023
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood, 2020, 09-10, Volume: 136, Issue:11 Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; DNA, Viral; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Viral Load; Vorinostat	2020
Induction Chemotherapy Reduces Radiation Therapy Dose and Volume in the Treatment of Intracranial Germinoma: Results of the SMC-G13 Trial. International journal of radiation oncology, biology, physics, 2020, 11-01, Volume: 108, Issue:3 Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Chorionic Gonadotropin, beta Subunit, Human; Cranial Irradiation; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Germinoma; Humans; Induction Chemotherapy; Male; Neutropenia; Pilot Projects; Progression-Free Survival; Prospective Studies; Proton Therapy; Radiotherapy Dosage; Radiotherapy, Conformal; Young Adult	2020
Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen. BJU international, 2021, Volume: 127, Issue:2 Topics: Adult; Antibiotics, Antineoplastic; Antiemetics; Antineoplastic Agents, Phytogenic; Bleomycin; Cisplatin; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Incidence; London; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neutropenia; Retrospective Studies; Sepsis; Treatment Outcome	2021
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. The Lancet. Oncology, 2017, Volume: 18, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Follow-Up Studies; Humans; Intention to Treat Analysis; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiation Pneumonitis; Small Cell Lung Carcinoma; Survival Rate	2017
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma. Leukemia & lymphoma, 2018, Volume: 59, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Histone Deacetylase Inhibitors; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Panobinostat; Survival Rate; Thrombocytopenia; Treatment Outcome; Young Adult	2018
Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707. Haematologica, 2017, Volume: 102, Issue:12 Topics: Adult; Age Factors; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Febrile Neutropenia; Humans; Lymphoma, T-Cell, Peripheral; Middle Aged; Neutropenia; Prednisone; Thrombocytopenia; Treatment Outcome; Vincristine	2017
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study. European journal of cancer (Oxford, England : 1990), 2018, Volume: 88 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Diphosphonates; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Imidazoles; Kaplan-Meier Estimate; Male; Methotrexate; Neutropenia; Osteosarcoma; Young Adult; Zoledronic Acid	2018
Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study. Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Radiosurgery; Small Cell Lung Carcinoma; Treatment Outcome	2014
A randomized, double-blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma. British journal of haematology, 2016, Volume: 174, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Management; Double-Blind Method; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Rituximab; Young Adult	2016
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 11-01, Volume: 34, Issue:31 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Diarrhea; Etoposide; Female; Humans; Ipilimumab; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Small Cell Lung Carcinoma; Treatment Outcome	2016
A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy. Investigational new drugs, 2009, Volume: 27, Issue:1 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Boronic Acids; Bortezomib; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Neutropenia; Pyrazines; Thrombocytopenia	2009
Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors. Cancer, 2009, Feb-01, Volume: 115, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Neoplasms; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Recurrence	2009
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study. Lung cancer (Amsterdam, Netherlands), 2009, Volume: 66, Issue:3 Topics: Administration, Oral; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Tegafur; Uracil	2009
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, May-20, Volume: 27, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cisplatin; Diarrhea; Etoposide; Female; Glucuronosyltransferase; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pharmacogenetics; Polymorphism, Single Nucleotide; Risk Factors; Small Cell Lung Carcinoma	2009
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival. Leukemia & lymphoma, 2009, Volume: 50, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation, Autologous; Young Adult	2009
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jun-20, Volume: 27, Issue:18 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Small Cell Lung Carcinoma; Survival Rate; Tirapazamine; Triazines	2009
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Male; Metabolic Clearance Rate; Neuroblastoma; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome	2010
Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Oct-01, Volume: 27, Issue:28 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fatigue; Female; Glutamates; Guanine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Pemetrexed; Small Cell Lung Carcinoma; Treatment Outcome	2009
Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study. Lung cancer (Amsterdam, Netherlands), 2010, Volume: 68, Issue:3 Topics: Aged; Camptothecin; Cisplatin; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiotherapy, Adjuvant; Small Cell Lung Carcinoma	2010
Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin. Leukemia & lymphoma, 2009, Volume: 50, Issue:11 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neutropenia; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Young Adult	2009
"Metronomic" chemotherapy in advanced soft tissue sarcomas. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Sarcoma; Treatment Outcome	2010
Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma. Cancer, 2010, May-15, Volume: 116, Issue:10 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Small Cell Lung Carcinoma	2010
Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma. Hematological oncology, 2010, Volume: 28, Issue:2 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisolone; Prognosis; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult	2010
Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma. Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Staging; Neutropenia; Podophyllotoxin; Polyethylene Glycols; Recombinant Proteins; Transplantation, Autologous; Young Adult	2010
Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors. Anti-cancer drugs, 2010, Volume: 21, Issue:10 Topics: Administration, Oral; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Neoplasms; Neutropenia; Salvage Therapy; Thrombocytopenia	2010
Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience. Leukemia & lymphoma, 2011, Volume: 52, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nausea; Neutropenia; Nose Neoplasms; Prednisone; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine; Vomiting	2011
Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer. Anti-cancer drugs, 2012, Volume: 23, Issue:3 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Thrombocytopenia; Treatment Outcome	2012
Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2012, Volume: 77, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Radiation Pneumonitis; Treatment Outcome	2012
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Aug-01, Volume: 18, Issue:15 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nasal Mucosa; Neutropenia; Prognosis; Prospective Studies; Steroids; Treatment Outcome; Young Adult	2012
Combination chemotherapy of alternating etoposide and carboplatin with weekly administration of irinotecan and cisplatin in extensive-stage small-cell lung cancer. Anticancer research, 2012, Volume: 32, Issue:10 Topics: Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Diarrhea; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Severity of Illness Index; Small Cell Lung Carcinoma; Thrombocytopenia; Treatment Outcome	2012
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Feb-20, Volume: 31, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult	2013
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemoradiotherapy; Cisplatin; Confidence Intervals; Dehydration; Disease-Free Survival; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Humans; Induction Chemotherapy; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Small Cell Lung Carcinoma	2013
Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen. The Tohoku journal of experimental medicine, 2013, Volume: 229, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Endpoint Determination; Etoposide; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Neutropenia; Prednisone; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine	2013
Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years. Haematologica, 2002, Volume: 87, Issue:8 Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemical and Drug Induced Liver Injury; Cytarabine; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Neutropenia; Remission Induction; Survival Analysis; Treatment Outcome	2002
Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors. Medical and pediatric oncology, 2002, Volume: 39, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Etoposide; Female; Germinoma; Humans; Male; Neutropenia; Ovarian Neoplasms; Prospective Studies; Survival Analysis; Testicular Neoplasms; Treatment Outcome	2002
A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma. Cancer, 2002, Oct-01, Volume: 95, Issue:7 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Topotecan	2002
Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 38, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease Progression; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival; Thrombocytopenia; Topotecan; Treatment Outcome	2002
Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study. Leukemia & lymphoma, 2002, Volume: 43, Issue:7 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Neutropenia; Prednisone; Survival Analysis; Vincristine	2002
Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group. Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:8 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Hyperbilirubinemia; Infection Control; Length of Stay; Leukemia, Myeloid; Male; Neutropenia; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Analysis; Thioguanine; Thrombocytosis; Treatment Outcome	2002
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Feb-01, Volume: 21, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Injections, Subcutaneous; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome	2003
Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507. British journal of cancer, 2003, Mar-24, Volume: 88, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Diarrhea; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Survival; Thrombocytopenia	2003
Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: association with severe myelotoxicity. Medical oncology (Northwood, London, England), 2003, Volume: 20, Issue:3 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Treatment Failure	2003
A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers. Lung cancer (Amsterdam, Netherlands), 2003, Volume: 42, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiation Pneumonitis; Survival Analysis; Thrombocytopenia; Treatment Outcome	2003
Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial. Cancer, 2003, Nov-15, Volume: 98, Issue:10 Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Estramustine; Etoposide; Fatigue; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Paclitaxel; Prostatic Neoplasms; Sepsis; Survival Analysis; Treatment Outcome	2003
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood, 2004, May-15, Volume: 103, Issue:10 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neutropenia; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous	2004
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours. British journal of cancer, 2004, Feb-09, Volume: 90, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neutropenia; Prognosis; Survival Analysis; Treatment Outcome; Vincristine	2004
Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial. British journal of haematology, 2004, Volume: 124, Issue:4 Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neutropenia; Opportunistic Infections; Remission Induction; Survival Analysis	2004
Protease inhibitors potentiate chemotherapy-induced neutropenia. Blood, 2004, Nov-01, Volume: 104, Issue:9 Topics: Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Drug Synergism; Etoposide; Female; Humans; Infections; Kinetics; Lymphoma, AIDS-Related; Male; Myeloablative Agonists; Neutropenia; Protease Inhibitors; Survival Analysis; Treatment Outcome	2004
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer. British journal of cancer, 2004, Aug-16, Volume: 91, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Salvage Therapy; Survival Analysis; Thrombocytopenia; Treatment Outcome	2004
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Aug-15, Volume: 10, Issue:16 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tirapazamine; Triazines; Vomiting	2004
Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Sep-01, Volume: 22, Issue:17 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Germinoma; Humans; Male; Neutropenia; Ovarian Neoplasms; Testicular Neoplasms	2004
The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma. Haematologica, 2004, Volume: 89, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoadjuvant Therapy; Neutropenia; Thrombocytopenia; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine	2004
Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:11 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Injections, Intravenous; Intestinal Neoplasms; Leukopenia; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Prognosis; Survival Rate; Treatment Outcome; Vincristine	2004
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jan-20, Volume: 23, Issue:3 Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome; Vincristine	2005
[VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Prednisone; Remission Induction; Survival Rate; Treatment Outcome; Vincristine	2005
Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma. The oncologist, 2005, Volume: 10, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vincristine	2005
Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer. Journal of the National Cancer Institute, 2005, May-04, Volume: 97, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Incidence; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prognosis; Recombinant Proteins; Severity of Illness Index; Survival Analysis; Transplantation, Autologous; Treatment Outcome	2005
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen. Lung cancer (Amsterdam, Netherlands), 2005, Volume: 48, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Thrombocytopenia; Topotecan; Treatment Outcome	2005
A randomized trial between two neoadjuvant chemotherapy protocols: CDDP + 5-FU versus CDDP + VP16 in advanced cancer of the head and neck. Oncology reports, 2005, Volume: 14, Issue:3 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Survival Analysis; Treatment Outcome; Vomiting	2005
Activity of cladribine combined with etoposide in heavily pretreated patients with indolent lymphoid malignancies. Chemotherapy, 2005, Volume: 51, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Etoposide; Female; Humans; Infections; Infusions, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Recurrence; Survival Analysis; Treatment Outcome	2005
Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma. Oncology, 2005, Volume: 69, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Pyruvaldehyde; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine	2005
Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma. Medical oncology (Northwood, London, England), 2005, Volume: 22, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prognosis	2005
A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin. Anti-cancer drugs, 2005, Volume: 16, Issue:9 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biphenyl Compounds; Carboplatin; Cohort Studies; Colonic Neoplasms; Enzyme Inhibitors; Etoposide; Female; Humans; Male; Matrix Metalloproteinase Inhibitors; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Neutropenia; Organic Chemicals; Phenylbutyrates; Thrombocytopenia; Thymoma; Treatment Outcome; Vomiting	2005
Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma. Bone marrow transplantation, 2005, Volume: 36, Issue:11 Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Mobilization; Humans; Infections; Multiple Myeloma; Neutropenia; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Thrombocytopenia	2005
A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer. Investigational new drugs, 2006, Volume: 24, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Etoposide; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Taxoids; Treatment Outcome	2006
Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Nov-01, Volume: 23, Issue:31 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Ciprofloxacin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Risk Factors; Roxithromycin; Treatment Outcome	2005
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34 Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Male; N-Myc Proto-Oncogene Protein; Neoplasm Staging; Neuroblastoma; Neutropenia; Nuclear Proteins; Oncogene Proteins; Ploidies; Prognosis; Risk Factors; Treatment Outcome	2005
A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Small Cell; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Etoposide; Female; Gastrointestinal Tract; Humans; Injections, Intravenous; Liver Function Tests; Lung Neoplasms; Male; Nausea; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting	2006
Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma. Annals of hematology, 2006, Volume: 85, Issue:10 Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neutropenia; Podophyllotoxin; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous	2006
Multicenter Phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma. Hematological oncology, 2006, Volume: 24, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisolone; Remission Induction; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine	2006
Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Nov-20, Volume: 24, Issue:33 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Disease-Free Survival; Etoposide; Female; Fever; Humans; Infections; Irinotecan; Japan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiotherapy Dosage; Radiotherapy, Adjuvant; Severity of Illness Index; Survival Analysis; Treatment Outcome	2006
Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Bilirubin; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Fatigue; Female; Humans; Ketoconazole; Male; Middle Aged; Neutropenia	2007
Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease. British journal of haematology, 2007, Volume: 136, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Survival Analysis; Treatment Outcome	2007
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. European journal of haematology, 2007, Volume: 78, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Sepsis; Survival Rate; Transplantation, Autologous; Treatment Outcome	2007
A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Diarrhea; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Survival Analysis; Thrombocytopenia; Treatment Outcome	2007
Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma. Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Platelet Count; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome	2007
DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients. Transfusion, 2008, Volume: 48, Issue:5 Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Injections, Subcutaneous; Leukapheresis; Male; Middle Aged; Multiple Myeloma; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome	2008
Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma. Cancer treatment reports, 1981, Volume: 65 Suppl 5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neutropenia; Parenteral Nutrition; Procarbazine; Vincristine	1981
Maturation of mobilized peripheral blood progenitor cells: preclinical and phase I clinical studies. Journal of hematotherapy, 1995, Volume: 4, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Differentiation; Cell Division; Colony-Forming Units Assay; Cryopreservation; Culture Techniques; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Growth Substances; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukapheresis; Neoplasms; Neutropenia; Thiotepa	1995
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group. British journal of cancer, 1994, Volume: 70, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Bone Marrow Transplantation; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Prednisolone; Retrospective Studies; Risk Factors; Vincristine; Vindesine	1994
Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutropenia; Neutrophils; Prospective Studies; Recombinant Proteins; Survival Rate; Transplantation, Autologous	1994
Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patients. Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2 Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Salvage Therapy; Treatment Outcome	1994
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lenograstim; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neutropenia; Neutrophils; Prognosis; Recombinant Proteins; Survival Rate; Vincristine	1995
P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL). Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisone; Prognosis; Remission Induction; Survival Rate; Vinblastine	1994
Economic analysis of prophylactic G-CSF after mini-BEAM salvage chemotherapy for Hodgkin's and non-Hodgkin's lymphoma. Leukemia & lymphoma, 1995, Volume: 17, Issue:1-2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Fever; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Length of Stay; Lymphoma, Non-Hodgkin; Melphalan; Neutropenia; Retrospective Studies; Salvage Therapy	1995
A phase I trial of paclitaxel and etoposide for metastatic or recurrent malignancies. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 6 Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia	1995
[Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients]. Zhonghua nei ke za zhi, 1994, Volume: 33, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cross-Over Studies; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins	1994
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Drug Tolerance; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Thrombocytopenia	1995
High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Heart Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Mitoxantrone; Neutropenia; Pilot Projects; Platelet Count; Remission Induction; Survival Rate; Vincristine	1995
Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12, Issue:1-2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Rate	1995
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7 Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Thrombocytopenia	1995
Paclitaxel by 1-hour infusion in combination chemotherapy of stage III non-small cell lung cancer. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Esophagitis; Etoposide; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intravenous; Leukopenia; Lung Neoplasms; Neoplasm Staging; Neutropenia; Paclitaxel; Radiotherapy; Remission Induction	1995
Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine	1995
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Colony-Stimulating Factors; Ethylenes; Etoposide; Female; Humans; Interleukin-1; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Remission Induction; Thrombocytopenia	1995
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Recurrence; Survival Analysis; Treatment Outcome; Vincristine	1993
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Small Cell; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins	1993
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neutropenia; Remission Induction; Thrombocytopenia; Vincristine	1995
A phase I trial of high-dose oral tamoxifen and CHOPE. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prednisone; Tamoxifen; Vincristine	1995
Phase I clinical and pharmacokinetic study of oral etoposide phosphate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1 Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Biological Availability; Drug Administration Schedule; Etoposide; Humans; Injections, Intravenous; Lymphoma; Middle Aged; Models, Biological; Neoplasms; Neutropenia; Organophosphorus Compounds; Prodrugs	1995
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Recombinant Proteins; Vinblastine	1995
[Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1994, Volume: 16, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cross-Over Studies; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins	1994
Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infections; Lung Neoplasms; Male; Middle Aged; Neutropenia; Remission Induction; Survival Analysis	1994
Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparison. Seminars in oncology, 1994, Volume: 21, Issue:5 Suppl 12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Germinoma; Humans; Male; Middle Aged; Neutropenia; Remission Induction; Seminoma; Survival Rate; Testicular Neoplasms	1994
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:9 Topics: Adult; Aged; Alopecia; Chromatography, High Pressure Liquid; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Neutropenia; Organophosphorus Compounds; Prodrugs; Regression Analysis; Solubility; Vomiting	1994
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial. Cancer, 1993, Apr-15, Volume: 71, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neutropenia; Thrombocytopenia	1993
Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia	1994
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Prospective Studies; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome	1993
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies. Cancer research, 1993, Dec-15, Volume: 53, Issue:24 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Thrombocytopenia	1993
Granulocyte-macrophage colony-stimulating factor given before dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP). Biotechnology therapeutics, 1993, Volume: 4, Issue:3-4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Escherichia coli; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Recombinant Proteins; Yeasts	1993
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer. Annals of hematology, 1993, Volume: 67, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neutropenia; Testicular Neoplasms; Treatment Outcome	1993
Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study. Cancer, 1993, Sep-01, Volume: 72, Issue:5 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Child; Drug Tolerance; Etoposide; Humans; Ifosfamide; Leukemia, Myeloid; Mesna; Neoplasm Recurrence, Local; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Urinary Tract	1993
A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide. British journal of cancer, 1993, Volume: 68, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Injections, Intraperitoneal; Kidney; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms	1993
Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Least-Squares Analysis; Male; Neoplasms; Neutropenia; Thrombocytopenia; Treatment Outcome	1993
A phase II trial of a chemotherapy combination in elderly patients with aggressive lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neutropenia; Prednisone; Remission Induction	1993
Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia. Leukemia, 1996, Volume: 10, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neutropenia; Pilot Projects; Remission Induction; Survival Rate	1996
Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Clinical oncology (Royal College of Radiologists (Great Britain)), 1995, Volume: 7, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins	1995
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin. American journal of hematology, 1996, Volume: 51, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Transfusion; Breast Neoplasms; Cisplatin; Cyclophosphamide; Double-Blind Method; Etoposide; Female; Gastrointestinal Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Length of Stay; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Platelet Count; Thrombocytopenia; Treatment Outcome	1996
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group. Blood, 1996, Apr-15, Volume: 87, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine	1996
Post-remission intensive consolidation with high-dose cytarabine-based chemotherapy and granulocyte colony-stimulatory factor in adults with acute myelogenous leukemia: a preliminary report. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1995, Volume: 56, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neutropenia; Remission Induction	1995
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer. American journal of clinical oncology, 1996, Volume: 19, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Confidence Intervals; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vomiting	1996
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:3 Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine	1996
Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood, 1996, Mar-01, Volume: 87, Issue:5 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Culture Techniques; Cells, Cultured; Combined Modality Therapy; Culture Media; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunomagnetic Separation; Leukapheresis; Lewis X Antigen; Melphalan; Middle Aged; Neutropenia; Tamoxifen; Thiotepa; Thrombocytopenia	1996
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia. Cancer, 1996, Jun-01, Volume: 77, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Disease Progression; Disease Susceptibility; Etoposide; Female; Gastrointestinal Diseases; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Remission Induction; Salvage Therapy	1996
Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions. Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:12 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Neutropenia; Prospective Studies; Remission Induction; Vindesine	1995
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. Neurology, 1996, Volume: 46, Issue:6 Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Epidural Space; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Middle Aged; Neutropenia; Ondansetron; Retrospective Studies; Salvage Therapy; Spinal Cord Neoplasms; Treatment Outcome; Vincristine	1996
Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot study. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Pilot Projects; Prednisone; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Analysis; Thrombocytopenia; Vincristine	1995
Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia	1996
Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Remission Induction; Salvage Therapy; Survival Rate; Topotecan; United States	1996
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma. Bone marrow transplantation, 1996, Volume: 17, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Diarrhea; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male; Melphalan; Neuroblastoma; Neutropenia; Remission Induction; Salvage Therapy; Stomatitis; Transplantation Conditioning; Vincristine	1996
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE). The Journal of infusional chemotherapy, 1996,Winter, Volume: 6, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia	1996
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer, 1996, Aug-15, Volume: 78, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Heart Failure; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Sarcoma, Ewing; Soft Tissue Neoplasms; Thrombocytopenia; Vincristine	1996
The limits of chemotherapy dose intensification using granulocyte colony stimulating factor alone in extensive small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 1996, Volume: 14, Issue:2-3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Neutropenia; Prospective Studies	1996
A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer. Anti-cancer drugs, 1996, Volume: 7, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Neutropenia	1996
Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery. Bone marrow transplantation, 1996, Volume: 18, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Life Tables; Lung Diseases, Interstitial; Male; Middle Aged; Neutropenia; Remission Induction; Treatment Outcome	1996
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer. American journal of clinical oncology, 1996, Volume: 19, Issue:6 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cause of Death; Dose-Response Relationship, Drug; Drug Tolerance; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Thrombocytopenia	1996
Prophylactic granulocyte colony-stimulating factor allows escalation of chemotherapeutic dose intensity in advanced epithelial ovarian cancer. Gynecologic oncology, 1996, Volume: 63, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Middle Aged; Neutropenia; Ovarian Neoplasms; Thrombocytopenia	1996
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano. British journal of cancer, 1996, Volume: 74, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cause of Death; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prognosis; Survival Analysis; Vinblastine; Vinorelbine	1996
Phase I/II trial of carboplatin dose escalation in combination chemotherapy with etoposide, bleomycin and GM-CSF support for poor prognosis nonseminomatous germ cell tumors patients. Neoplasma, 1996, Volume: 43, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Etoposide; Germinoma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Neutropenia; Prognosis	1996
Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Rate; Thrombocytopenia	1996
The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia; Treatment Outcome	1996
Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myeloma. British journal of haematology, 1997, Volume: 96, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Etoposide; Female; Humans; Idarubicin; Male; Middle Aged; Multiple Myeloma; Neutropenia; Survival Rate; Treatment Outcome	1997
[Chemotherapy schedules and bacteremia in adult patients with acute leukemia]. Medicina, 1996, Volume: 56, Issue:4 Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Cytarabine; Daunorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia; Male; Mitoxantrone; Neutropenia; Risk Factors	1996
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia. Cancer letters, 1997, May-19, Volume: 115, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cross-Over Studies; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lung Neoplasms; Male; Neutropenia; Platelet Count; Sarcoma	1997
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer. Japanese journal of clinical oncology, 1997, Volume: 27, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Survival Analysis	1997
Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Mesna; Middle Aged; Neutropenia; Patient Selection; Recombinant Proteins; Thiotepa	1997
Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neutropenia; Sarcoma, Kaposi	1997
Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: a report from the Australia and New Zealand Children's Cancer Study Group. Medical and pediatric oncology, 1997, Volume: 29, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infant; Neoplasm Recurrence, Local; Neoplasms; Neutropenia; Vincristine	1997
Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer. American journal of clinical oncology, 1997, Volume: 20, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease Progression; Drug Administration Schedule; Estramustine; Etoposide; Humans; Male; Middle Aged; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Vinblastine; Vinorelbine	1997
Dose-intensive chemotherapy in extensive-stage small-cell lung cancer. Cancer chemotherapy and pharmacology, 1997, Volume: 40 Suppl Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neutropenia; Treatment Outcome; Vincristine	1997
Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940. Cancer investigation, 1997, Volume: 15, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Interleukin-1; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia	1997
Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial. American journal of clinical oncology, 1997, Volume: 20, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cause of Death; Cisplatin; Clinical Trials, Phase II as Topic; Cochlea; Digestive System Neoplasms; Drug Administration Schedule; Drug Synergism; Esophageal Neoplasms; Etoposide; Evaluation Studies as Topic; Female; Humans; Kidney; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Remission Induction; Sepsis; Stomach Neoplasms; Thrombocytopenia; Vomiting	1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant; Infections; Infusions, Intravenous; Leukopenia; Male; Neuroblastoma; Neutropenia; Thrombocytopenia; Treatment Outcome; Vincristine	1997
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor Annals of hematology, 1997, Volume: 75, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphocyte Count; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neutropenia; Prednisolone; Recombinant Proteins; Vincristine	1997
The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Time Factors	1997
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy. Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Half-Life; Humans; Ifosfamide; Infant; Interleukin-3; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Recombinant Fusion Proteins	1998
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma. Cancer, 1998, Jan-15, Volume: 82, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Etoposide; Female; Granulocytes; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vomiting	1998
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study. International journal of radiation oncology, biology, physics, 1998, Jan-15, Volume: 40, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Thrombocytopenia	1998
A phase II study of carboplatin and prolonged administration of oral etoposide in patients with small-cell lung cancer. Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:7 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Rate; Thrombocytopenia	1997
Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin. International journal of clinical pharmacology and therapeutics, 1998, Volume: 36, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Cyclophosphamide; Cyclosporine; Dactinomycin; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Immunosuppressive Agents; Neutropenia; Patient Admission; Retrospective Studies; Sarcoma; Sepsis; Soft Tissue Neoplasms; Vincristine	1998
Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Recurrence; Survival Rate; Treatment Outcome; Vincristine	1998
Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Analysis; Treatment Outcome	1998
Randomized clinical study comparing aggressive chemotherapy with or without G-CSF support for high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia evolving from MDS. British journal of haematology, 1998, Volume: 102, Issue:3 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Gene Rearrangement; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Recurrence; Survival Analysis; Treatment Outcome	1998
A study of filgrastim (rG-CSF) priming of etoposide/cisplatin in advanced non-small cell lung cancer. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 1998, Volume: 18, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins	1998
Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial. German AML Cooperative Group. Leukemia, 1998, Volume: 12, Issue:10 Topics: Aclarubicin; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Neutropenia; Prospective Studies; Recurrence; Stomatitis; Survival Rate	1998
Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10 Topics: Adolescent; Adult; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Capillary Leak Syndrome; Combined Modality Therapy; Cytokines; Drug Synergism; Etoposide; Feasibility Studies; Female; Femoral Neoplasms; Fever; Fibrosis; Gastrointestinal Diseases; Humans; Hypotension; Immunologic Factors; Interleukin-1; Lung Neoplasms; Male; Neutropenia; Osteosarcoma; Recombinant Proteins; Remission Induction; Respiration Disorders; Salvage Therapy; Treatment Outcome	1997
Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Interleukin-3; Leukocyte Count; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Platelet Count; Premedication; Safety; Thrombocytopenia; Treatment Outcome	1997
[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13 Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Thrombocytopenia; Uterine Cervical Neoplasms	1998
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infant; Male; Neuroblastoma; Neutropenia; Recombinant Proteins; Treatment Outcome; Vincristine	1998
High single dose of mitoxantrone and cytarabine in acute non-lymphocytic leukemia: a pharmacokinetic and clinical study. Therapeutic drug monitoring, 1998, Volume: 20, Issue:6 Topics: Adult; Aged; Amsacrine; Chromatography, High Pressure Liquid; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neutropenia; Time Factors	1998
Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group. Cancer, 1999, Feb-15, Volume: 85, Issue:4 Topics: Adult; Aged; Agranulocytosis; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome	1999
Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group. Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC, 1998, Volume: 2, Issue:4 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Canada; Cisplatin; Confidence Intervals; Disease-Free Survival; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Meta-Analysis as Topic; Neoplasms; Neutropenia; Odds Ratio; Quality of Life; Treatment Outcome; Vincristine	1998
Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol. Haematologica, 1999, Volume: 84, Issue:3 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Combined Modality Therapy; Cytarabine; Diarrhea; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infections; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neoplastic Stem Cells; Neutropenia; Remission Induction; Salvage Therapy; Treatment Outcome	1999
A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group. Cancer, 1999, Oct-15, Volume: 86, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pulmonary Fibrosis; Radiotherapy; Radiotherapy Dosage; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; Vindesine	1999
Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel	1999
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome	1999
A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Survival Rate; Time Factors	1999
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients. Journal of cancer research and clinical oncology, 1999, Volume: 125, Issue:12 Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine	1999
Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas. Medical and pediatric oncology, 2000, Volume: 34, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Mesna; Mouth Mucosa; Neoplasm Metastasis; Neutropenia; Prospective Studies; Remission Induction; Sarcoma; Stomatitis; Time Factors; Treatment Outcome; Vincristine	2000
Effects of G-CSF and high-dose methylprednisolone on peripheral stem cells, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia: a pilot study. Leukemia research, 2000, Volume: 24, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Interleukin-3; Methotrexate; Methylprednisolone; Neutropenia; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine	2000
Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomize Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Quality of Life; Thrombocytopenia	2000
Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:4 Topics: Acute Disease; Adolescent; Adult; Amsacrine; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Length of Stay; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neutropenia; Recombinant Proteins; Remission Induction; Treatment Outcome	2000
High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone marrow transplantation, 2000, Volume: 25, Issue:5 Topics: Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Carmustine; CD4-CD8 Ratio; Cytarabine; Etoposide; Female; Fever; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infections; Leukapheresis; Lymphocyte Subsets; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Sclerosis; Neutropenia; Prognosis; Severity of Illness Index	2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vincristine	2000
Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer. Gynecologic oncology, 2000, Volume: 77, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Taxoids; Thrombocytopenia; Treatment Outcome	2000
Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy. Cytokines, cellular & molecular therapy, 1999, Volume: 5, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Necrosis; Neutropenia; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Stomatitis; Survival Analysis	1999
A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma. Cancer, 2000, Jun-15, Volume: 88, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Neuroblastoma; Neutropenia; Thrombocytopenia; Treatment Outcome	2000
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. Oncology, 2000, Volume: 59, Issue:1 Topics: Adenocarcinoma; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Cytokines; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukocyte Count; Middle Aged; Neutropenia; Thrombocytopenia	2000
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:16 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Thrombocytopenia	2000
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:16 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Treatment Outcome	2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy. Leukemia & lymphoma, 2000, Volume: 37, Issue:5-6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Prognosis; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation Conditioning; Treatment Outcome	2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. British journal of cancer, 2000, Volume: 83, Issue:12 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Seminoma; Survival Analysis; Testicular Neoplasms; Thrombocytopenia; Time Factors; Treatment Outcome	2000
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer. British journal of cancer, 2001, Jan-05, Volume: 84, Issue:1 Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Thrombocytopenia	2001
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Leukocyte Count; Male; Neoplasms; Neutropenia; Neutrophils; Prospective Studies; Racial Groups; Recombinant Proteins; Recurrence; Survival Rate; Time Factors; United States	2001
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:4 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Fatigue; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Paclitaxel; Survival Rate; Thrombocytopenia; Treatment Outcome; Vomiting	2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study. Leukemia, 2001, Volume: 15, Issue:6 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Injections, Intravenous; Life Tables; Male; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine	2001
Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients. Medical and pediatric oncology, 2001, Volume: 36, Issue:1 Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays	2001
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854. Cancer, 2001, Jul-15, Volume: 92, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Treatment Outcome; Vincristine	2001
Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:8 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Fatigue; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Paclitaxel; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting	2001
Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer. Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:7 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Neutropenia; Severity of Illness Index; Thrombocytopenia; Treatment Outcome	2001
Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study. International journal of radiation oncology, biology, physics, 2001, Sep-01, Volume: 51, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Fever; Follow-Up Studies; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Quality of Life; Radiodermatitis; Radiotherapy Dosage; Skin Neoplasms	2001
Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study. Bone marrow transplantation, 2001, Volume: 28, Issue:3 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infections; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Survival Analysis; Treatment Outcome	2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine	2001
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:9 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome	2001
A multicenter trial of infusional etoposide, doxorubicin, and vincristine with cyclophosphamide and prednisone (EPOCH) in patients with relapsed non-Hodgkin's lymphoma. Clinical lymphoma, 2001, Volume: 1, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Growth Substances; Humans; Hydro-Lyases; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Prednisone; Survival Rate; Treatment Outcome; Vincristine	2001
Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 35, Issue:1 Topics: Administration, Oral; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neutropenia; Survival Rate; Treatment Outcome	2002
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Fever; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Infections; Infusions, Intravenous; Lung Neoplasms; Macrolides; Male; Middle Aged; Neutropenia; Placebos; Survival Analysis; Treatment Outcome	2001
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-15, Volume: 20, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Male; Neoplasm Metastasis; Neutropenia; Osteosarcoma; Thrombocytopenia; Treatment Outcome	2002
A phase I study of sequential intravenous topotecan and etoposide in lung cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Treatment Outcome	2001
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. Blood, 2002, Apr-15, Volume: 99, Issue:8 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Monitoring; Etoposide; Female; Humans; Longitudinal Studies; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Platelet Count; Prednisone; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine	2002
Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial. Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pilot Projects; Remission Induction; Survival Rate; Thrombocytopenia	1992
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood, 1992, Sep-15, Volume: 80, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Survival Rate; Vincristine	1992
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer. Journal of cancer research and clinical oncology, 1992, Volume: 119, Issue:1 Topics: Carboplatin; Cisplatin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Neutropenia; Ovarian Neoplasms	1992
A dose-escalation study of carboplatin/cyclophosphamide/etoposide along with autologous bone marrow or peripheral blood stem cell rescue. Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 2 Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Bone Marrow Transplantation; Candidiasis; Carboplatin; Clinical Trials, Phase I as Topic; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intravenous; Male; Neutropenia; Remission Induction; Stem Cells; Survival Rate; Thrombocytopenia	1992
Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Bone marrow transplantation, 1992, Volume: 10, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Neuroblastoma; Neutropenia; Thrombocytopenia	1992
Placebo controlled phase I/II study of subcutaneous GM-CSF in patients with germ cell tumors undergoing chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Recombinant Proteins; Vinblastine	1990
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. The New England journal of medicine, 1991, Jul-18, Volume: 325, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Administration Schedule; Etoposide; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Length of Stay; Lung Neoplasms; Neutropenia; Recombinant Proteins; Survival Rate	1991
GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease. Bone marrow transplantation, 1989, Volume: 4, Issue:1 Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Colony-Stimulating Factors; Combined Modality Therapy; Cytarabine; Drug Evaluation; Etoposide; Granulocytes; Hodgkin Disease; Humans; Leukocyte Count; Macrophages; Melphalan; Neutropenia; Neutrophils; Postoperative Complications; Recombinant Proteins; Transplantation, Autologous	1989
Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:1 Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cats; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Combinations; Etoposide; Female; Humans; Infection Control; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine; Vomiting	1985
A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia. Blut, 1988, Volume: 56, Issue:5 Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Humans; Infections; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Remission Induction; Thrombocytopenia	1988

Other Studies

152 other study(ies) available for etoposide and Neutropenia

Article	Year
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma. Cancer medicine, 2022, Volume: 11, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Etoposide; Humans; Irinotecan; Neoplasm Recurrence, Local; Neuroblastoma; Neutropenia; Retrospective Studies	2022
Modified EPOCH for high-risk non-Hodgkin lymphoma in sub-Saharan Africa. Cancer medicine, 2020, Volume: 9, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Malawi; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; RNA, Viral; Vincristine; Young Adult	2020
Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study. BMC cancer, 2020, Aug-12, Volume: 20, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Middle Aged; Neutropenia; Progression-Free Survival; Radiotherapy; Rare Diseases; Risk; Thrombocytopenia; Young Adult	2020
Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting. BMC cancer, 2020, Aug-24, Volume: 20, Issue:1 Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hepatic Encephalopathy; HIV Infections; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Retrospective Studies; Sepsis; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; Uganda; Vincristine	2020
Prognostic Factors in Childhood Acute Myeloid Leukemia; Experience from A Developing Country. Cancer reports (Hoboken, N.J.), 2020, Volume: 3, Issue:5 Topics: Adolescent; Child; Child, Preschool; Consolidation Chemotherapy; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Malnutrition; Neutropenia; Pakistan; Prognosis; Progression-Free Survival; Risk Assessment; Risk Factors; Sepsis; Survival Rate	2020
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status. Oncology, 2018, Volume: 94, Issue:4 Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Female; Health Status; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Thrombocytopenia	2018
Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis. International journal of radiation oncology, biology, physics, 2018, 03-01, Volume: 100, Issue:3 Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neutropenia; Organs at Risk; Paclitaxel; Probability; Radiation Dosage; Retrospective Studies; ROC Curve; Small Cell Lung Carcinoma; Thoracic Vertebrae	2018
Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer. International journal of clinical oncology, 2019, Volume: 24, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carboplatin; Cisplatin; Etoposide; Female; Glucuronosyltransferase; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Neutropenia; Polymorphism, Genetic; Retrospective Studies; Small Cell Lung Carcinoma; Thrombocytopenia	2019
Safety and Cost-effectiveness of Outpatient Administration of High-dose Chemotherapy in Children With Ewing Sarcoma. Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neutropenia; Outpatients; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; Vincristine	2019
Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM. Bone marrow transplantation, 2014, Volume: 49, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; C-Reactive Protein; Carmustine; Case-Control Studies; Cytarabine; Etoposide; Febrile Neutropenia; Female; Fibroblast Growth Factor 7; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Intestinal Mucosa; Male; Melphalan; Middle Aged; Mucositis; Neutropenia; Young Adult	2014
Clozapine, cancer chemotherapy and neutropenia - dilemmas in management. Psychiatria Danubina, 2013, Volume: 25, Issue:4 Topics: Adult; Antineoplastic Agents; Antipsychotic Agents; Bleomycin; Breast Neoplasms; Carcinoma; Cisplatin; Clozapine; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Schizophrenia; Seminoma; Testicular Neoplasms	2013
Pegfilgrastim-induced pain in patients with lymphoma. Oncology nursing forum, 2014, Mar-01, Volume: 41, Issue:2 Topics: Acute Pain; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neutropenia; Oncology Nursing; Polyethylene Glycols; Prednisone; Recombinant Proteins; Rituximab; Vincristine	2014
MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients. Oncology research and treatment, 2014, Volume: 37, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; China; Cisplatin; Etoposide; Female; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neutropenia; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-mdm2; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome; Tumor Suppressor Protein p53	2014
Dose schedule optimization and the pharmacokinetic driver of neutropenia. PloS one, 2014, Volume: 9, Issue:10 Topics: Animals; Antineoplastic Agents; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Male; Models, Biological; Models, Theoretical; Neutropenia; Rats, Sprague-Dawley; Taxoids; Topotecan	2014
[Necrotizing gastritis in a patient in severe neutropenia]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2014, Volume: 37, Issue:222 Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Enteral Nutrition; Esophagostomy; Etoposide; Female; Gastrectomy; Gastritis; Gastrointestinal Hemorrhage; Heart Arrest; Hodgkin Disease; Humans; Jejunostomy; Neutropenia; Prednisone; Procarbazine; Stents; Vincristine	2014
Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience. Clinical lung cancer, 2015, Volume: 16, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Etoposide; Female; Humans; Induction Chemotherapy; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Staging; Neutropenia; Small Cell Lung Carcinoma; Topotecan; Treatment Outcome	2015
Optimization of drug regimen in chemotherapy based on semi-mechanistic model for myelosuppression. Journal of biomedical informatics, 2015, Volume: 57 Topics: Antineoplastic Agents; Etoposide; Humans; Models, Theoretical; Neoplasms; Neutropenia	2015
Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer. American journal of clinical oncology, 2017, Volume: 40, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Docetaxel; Etoposide; Female; Hemoglobins; Humans; Leukopenia; Logistic Models; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Severity of Illness Index; Survival Rate; Taxoids; Thrombocytopenia	2017
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma. European journal of gynaecological oncology, 2015, Volume: 36, Issue:3 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Hepatic Insufficiency; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine	2015
[A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Dialysis; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Small Cell Lung Carcinoma	2016
[Efficiency and adverse effects of the effective therapy applying etoposide + cisplatin and its subsequent maintenance therapy with different durations in patients with small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2016, Jun-23, Volume: 38, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Humans; Hypokinesia; Leukopenia; Lung Neoplasms; Nausea; Neutropenia; Remission Induction; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Thrombocytopenia; Vomiting	2016
Efficacy of Ifosfamide-Cisplatin-Etoposide (ICE) Chemotherapy for a CNS Germinoma in a Child With Down Syndrome. Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Cisplatin; Cranial Irradiation; Down Syndrome; Etoposide; Germinoma; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neutropenia; Paresis; Remission Induction; Supratentorial Neoplasms	2017
Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. Bone marrow transplantation, 2009, Volume: 43, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Carmustine; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphoproliferative Disorders; Male; Melphalan; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Rituximab; Vidarabine; Young Adult	2009
Testicular abscess an unusual cause for febrile neutropenia. TheScientificWorldJournal, 2008, Oct-03, Volume: 8 Topics: Abscess; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Fever; Humans; Male; Neutropenia; Orchiectomy; Surgical Wound Infection; Testicular Diseases; Testicular Neoplasms	2008
Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity. Cytotherapy, 2009, Volume: 11, Issue:3 Topics: Adolescent; Adult; Antigens, CD34; Child; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Male; Middle Aged; Neutropenia; Thrombocytopenia; Transplantation Conditioning; Treatment Outcome; Vomiting	2009
A tool for neutrophil guided dose adaptation in chemotherapy. Computer methods and programs in biomedicine, 2009, Volume: 93, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Protocols; Bayes Theorem; Bone Marrow Diseases; Drug Administration Schedule; Etoposide; Humans; Neutropenia; Neutrophils	2009
Intermediate dose gemcitabine-cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting--a new standard of care in relapsed or refractory Hodgkin lymphoma? Annals of hematology, 2009, Volume: 88, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Cisplatin; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Methylprednisolone; Middle Aged; Neutropenia; Recurrence; Retrospective Studies; Salvage Therapy; Transplantation, Autologous; Young Adult	2009
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in adolescents. Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7 Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Cisplatin; Cyclophosphamide; Double-Blind Method; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Incidence; Morpholines; Nausea; Neutropenia; Randomized Controlled Trials as Topic; Sample Size; Vomiting	2009
Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma. Leukemia & lymphoma, 2009, Volume: 50, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Monitoring; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Leukemia-Lymphoma, Adult T-Cell; Metabolic Networks and Pathways; Neoplasm Proteins; Neoplastic Cells, Circulating; Neutropenia; Nitrosourea Compounds; Prednisone; Receptors, Interleukin-2; Tryptophan; Tryptophan Oxygenase; Vincristine; Vindesine	2009
Population analysis of myelosuppression profiles using routine clinical data after the ICE (ifosfamide/carboplatin/etoposide) regimen for malignant gliomas. Journal of pharmaceutical sciences, 2009, Volume: 98, Issue:11 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Computer Simulation; Etoposide; Female; Glioma; Humans; Ifosfamide; Immunosuppressive Agents; Kinetics; Leukocyte Count; Male; Middle Aged; Models, Statistical; Monte Carlo Method; Neutropenia; Platelet Count; Reticulocyte Count; Retrospective Studies	2009
Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC? Nature reviews. Clinical oncology, 2009, Volume: 6, Issue:10 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Camptothecin; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Diarrhea; Drug Therapy; Drug Therapy, Combination; Enzyme Inhibitors; Ethnicity; Etoposide; Female; Follow-Up Studies; Glucuronosyltransferase; Humans; Irinotecan; Lung Neoplasms; Male; Neutropenia; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Survival Analysis; Therapeutic Equivalency; Time Factors; Treatment Outcome	2009
A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule. Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neutropenia; Polyethylene Glycols; Prognosis; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Young Adult	2010
[Hematological toxicity of some combined chemotherapy schemes involving aranoza]. Eksperimental'naia i klinicheskaia farmakologiia, 2010, Volume: 73, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Etoposide; Glycosides; Hematologic Tests; Irinotecan; Lymphopenia; Male; Methylnitrosourea; Mice; Mice, Inbred BALB C; Neutropenia; Topotecan	2010
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Oct-20, Volume: 28, Issue:30 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cell Proliferation; Deoxycytidine; Etoposide; Female; France; Gemcitabine; Humans; Leukocyte Count; Male; Middle Aged; Models, Biological; Neutropenia; Neutrophils; Paclitaxel; Platelet Count; Prospective Studies; Risk Assessment; Risk Factors; Thrombocytopenia; Young Adult	2010
Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Neutropenia; Retrospective Studies; Thymus Neoplasms; Treatment Outcome; Vincristine	2011
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. Anti-cancer drugs, 2012, Volume: 23, Issue:3 Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cerebellar Neoplasms; Cytarabine; Etoposide; Humans; Injections, Spinal; Liposomes; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neutropenia; Pyrazoles; Sulfonamides; Thalidomide; Treatment Outcome	2012
Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia. American journal of hematology, 2012, Volume: 87, Issue:3 Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Etoposide; Feasibility Studies; Female; Humans; Infections; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neutropenia; Outpatients; Patient Readmission	2012
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole	2013
[Neutropenia and fever of unknown origin]. Praxis, 2012, Nov-28, Volume: 101, Issue:24 Topics: Algorithms; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Etoposide; Fever of Unknown Origin; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Prognosis; Testicular Neoplasms; Young Adult	2012
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization. Bone marrow transplantation, 2002, Volume: 30, Issue:5 Topics: Ambulatory Care; Antibiotic Prophylaxis; Cefepime; Cephalosporins; Ciprofloxacin; Clarithromycin; Data Collection; Drug Therapy, Combination; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Vancomycin	2002
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma. European journal of haematology, 2003, Volume: 70, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine	2003
Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor. Annals of hematology, 2003, Volume: 82, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Neutropenia; Recurrence; Remission Induction; Thrombocytopenia; Tomography, X-Ray Computed; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2003
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia, 2004, Volume: 18, Issue:1 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteria; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Down Syndrome; Etoposide; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Leukemia, Myeloid; Male; Mitoxantrone; Neutropenia; Prospective Studies; Retrospective Studies; Thioguanine	2004
Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation. International journal of hematology, 2004, Volume: 79, Issue:1 Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Graft Survival; Hematopoiesis; Humans; Idarubicin; Ifosfamide; Infections; Male; Middle Aged; Multiple Myeloma; Neutropenia; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation	2004
[Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen]. Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Treatment Outcome; Vincristine	2004
Potential antiretroviral drug interactions with cyclophosphamide, Doxorubicin, and Etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-20, Volume: 23, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Drug Interactions; Etoposide; Humans; Lymphoma, AIDS-Related; Neutropenia; Protease Inhibitors	2005
[Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma]. Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thrombocytopenia; Transplantation, Autologous	2005
Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, May-15, Volume: 11, Issue:10 Topics: Anemia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Cell Culture Techniques; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Etoposide; Female; Leukopenia; Mice; Neutropenia; Razoxane; Thrombocytopenia	2005
IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation. American journal of clinical oncology, 2005, Volume: 28, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Infections; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome	2005
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutation research, 2005, Jun-06, Volume: 583, Issue:2 Topics: Animals; Area Under Curve; Azure Stains; Bone Marrow Cells; Chromosome Aberrations; Chromosome Painting; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Etoposide; Infusions, Intravenous; Macaca mulatta; Neutropenia; Paclitaxel; Thiotepa	2005
Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:1 Topics: Acetaminophen; Acid-Base Equilibrium; Acidosis; Adult; Analgesics, Non-Narcotic; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Candidiasis; Chlorides; Cytarabine; Etoposide; Fatal Outcome; Fever; Humans; Ifosfamide; Kidney Tubular Necrosis, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Neutropenia; Polycystic Kidney, Autosomal Dominant; Pyrrolidonecarboxylic Acid; Salvage Therapy; Systemic Inflammatory Response Syndrome	2005
Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience. Clinical oncology (Royal College of Radiologists (Great Britain)), 2005, Volume: 17, Issue:4 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycins; Neoplasm Metastasis; Neutropenia; Retrospective Studies; Salvage Therapy; Taxoids; Treatment Outcome; United Kingdom; Vinblastine	2005
[Combined radiochemotherapy in localised small-cell lung cancer. Concurrent treatment protocols?]. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2005, Volume: 7, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Esophagitis; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Radiation Pneumonitis; Radiotherapy; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome	2005
[Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases]. Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Nose Neoplasms; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Vincristine	2005
Population pharmacokinetic-pharmacodynamic model for neutropenia with patient subgroup identification: comparison across anticancer drugs. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Sep-15, Volume: 12, Issue:18 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Drug Interactions; Etoposide; Female; Humans; Liver; Male; Middle Aged; Models, Theoretical; Neutropenia; Neutrophils; Paclitaxel; Sex Characteristics; Taxoids; Topotecan	2006
The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2006, Volume: 54, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Fever; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Treatment Outcome	2006
[Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nausea; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Remission Induction; Temozolomide; Young Adult	2006
[Efficacy of adriamycin, etoposide plus ifosfamide on small cell lung cancer--a retrospective analysis of 69 cases treated in Centre Hospitalo-Universitaire de Bordeaux]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:12 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Remission Induction; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate	2006
Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma. Lung cancer (Amsterdam, Netherlands), 2007, Volume: 57, Issue:1 Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Thrombocytopenia; Time Factors; Topotecan	2007
[Outpatient chemotherapy for lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:4 Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gefitinib; Gemcitabine; Humans; Informed Consent; Irinotecan; Lung Neoplasms; Neutropenia; Paclitaxel; Quality of Life; Quinazolines; Taxoids; Vinblastine; Vinorelbine	2007
Paraneoplastic Sweet's syndrome and the pathergy phenomenon. Annals of hematology, 2007, Volume: 86, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Drug Eruptions; Etoposide; Female; Humans; Inflammation; Leukemia, Monocytic, Acute; Middle Aged; Mitoxantrone; Neutropenia; Paraneoplastic Syndromes; Sweet Syndrome	2007
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Hydrocortisone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Piperazines; Salvage Therapy; Survival Rate; Thrombocytopenia; Vincristine	2007
[Results of dose-intense, dose-impact weekly combination chemotherapy with rituximab for patients with CD 20-positive B-cell non-Hodgkin's lymphoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neutropenia; Rituximab; Vincristine	2007
Comment on: 'Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome'. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:7 Topics: Administration, Oral; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Multicenter Studies as Topic; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine	2008
High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:4 Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Choriocarcinoma; Combined Modality Therapy; Drug Evaluation; Drug Resistance; Dysgerminoma; Etoposide; Female; Humans; Male; Nausea; Neutropenia; Podophyllotoxin; Pregnancy; Teratoma; Vomiting	1984
Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin. Cancer treatment reports, 1984, Volume: 68, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Thrombocytopenia	1984
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood, 1982, Volume: 60, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Inflammation; Lymphoma; Methotrexate; Mucous Membrane; Neutropenia; Podophyllotoxin; Recurrence	1982
Mesna/ifosfamide, mitoxantrone, etoposide, bleomycin, vincristine, prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphoma. Acta oncologica (Stockholm, Sweden), 1995, Volume: 34, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematuria; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Recurrence; Survival Rate; Vincristine	1995
[Relations between hematological toxicity and total and free plasma levels of etoposide in daily oral administration]. Bulletin du cancer, 1995, Volume: 82, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Availability; Drug Administration Schedule; Etoposide; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutropenia; Neutrophils	1995
Prevention of chemotherapy-induced neutropenia using G-CSF with VACOP-B--a case report. Leukemia & lymphoma, 1993, Volume: 11, Issue:5-6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Vincristine	1993
Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone marrow transplantation, 1994, Volume: 13, Issue:4 Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Blood Transfusion, Autologous; Breast Neoplasms; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Humans; Immunologic Factors; Leukapheresis; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Ovarian Neoplasms	1994
Clostridium septicum abscess in hepatic metastases: successful medical management. Bone marrow transplantation, 1994, Volume: 13, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Ceftazidime; Cisplatin; Clindamycin; Clostridium Infections; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Gases; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunocompromised Host; Liver Abscess; Liver Neoplasms; Methotrexate; Neutropenia; Sepsis	1994
Dose intensification in the treatment of patients with testicular germ cell tumours. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Testicular Neoplasms; Vincristine	1994
Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy. Cancer research, 1995, Jan-15, Volume: 55, Issue:2 Topics: Anemia; Animals; Bone Marrow; Bone Marrow Cells; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Macrophages; Mice; Mice, Inbred C57BL; Neutropenia; Regression Analysis; Spleen	1995
Fetal marrow suppression after maternal chemotherapy for leukaemia. Archives of disease in childhood. Fetal and neonatal edition, 1994, Volume: 71, Issue:3 Topics: Acute Disease; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infant, Newborn; Infant, Premature, Diseases; Leukemia, Myeloid; Neutropenia; Pregnancy; Pregnancy Complications, Neoplastic; Prenatal Exposure Delayed Effects	1994
Pseudoleukemia after granulocyte colony-stimulating factor therapy. Southern medical journal, 1995, Volume: 88, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myelomonocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasms, Second Primary; Neutropenia; Prednisone; Vincristine	1995
The feasibility of using glycosylated recombinant human granulocyte colony-stimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer. Medical Research European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Palliative Care; Thrombocytopenia	1995
Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Neoplasm Staging; Neutropenia; Sarcoma; Thrombocytopenia; Time Factors	1995
Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan. Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Adhesion Molecules; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Luminescent Measurements; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Proteins; Neutropenia; Neutrophils; Prednisone; Recombinant Proteins; Respiratory Burst; Vincristine	1995
Predicting neutropenia after chemotherapy for lymphoma. Leukemia & lymphoma, 1993, Volume: 9, Issue:1-2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukocyte Count; Lymphoma; Male; Mechlorethamine; Middle Aged; Neutropenia; Predictive Value of Tests; Prednisolone; Procarbazine; Retrospective Studies; Risk Factors; Thrombocytopenia; Vinblastine; Vincristine	1993
Delayed neutrophil recovery after BEAM chemotherapy and autologous bone marrow transplantation for lymphoma is not associated with increased mortality from infection. Bone marrow transplantation, 1995, Volume: 15, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cell Count; Combined Modality Therapy; Cytarabine; Etoposide; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; Neutropenia; Opportunistic Infections; Survival Analysis	1995
Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy. Medical and pediatric oncology, 1994, Volume: 23, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Fever; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia	1994
E-SHAP: an effective treatment in selected patients with relapsed non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neutropenia; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia	1994
21-day schedule oral etoposide in children--a feasibility study. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:16 Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Leukemia; Leukopenia; Male; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Treatment Outcome	1993
[Neutropenic typhlitis: a frequently missed complication of aplasia-inducing tumor therapy with a possible association to the combination of etoposide with high-dose cytosine-arabinoside]. Schweizerische medizinische Wochenschrift, 1994, Feb-05, Volume: 124, Issue:5 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Synergism; Enterocolitis, Pseudomembranous; Etoposide; Female; Humans; Leukemia; Male; Neutropenia; Retrospective Studies	1994
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer. Cancer, 1994, Apr-01, Volume: 73, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia	1994
[Neutropenic colitis following chemotherapy for malignancy]. Harefuah, 1994, Feb-15, Volume: 126, Issue:4 Topics: Aged; Anti-Bacterial Agents; Enterocolitis; Etoposide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes; Male; Neutropenia; Tomography, X-Ray Computed	1994
Pilot study of sequential combination chemotherapy in advanced and recurrent retinoblastoma. Medical and pediatric oncology, 1994, Volume: 22, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Eye Neoplasms; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neutropenia; Pilot Projects; Remission Induction; Retinoblastoma	1994
Low-dose oral etoposide in epithelial cancer of the ovary. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:6 Topics: Administration, Oral; Adult; Aged; Biological Availability; Carcinoma; Etoposide; Female; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Remission Induction; Salvage Therapy	1993
Hepatic candidiasis: persistent pyrexia in a patient with acute myeloid leukaemia after recovery from consolidation therapy-induced neutropenia. Annals of the Academy of Medicine, Singapore, 1993, Volume: 22, Issue:2 Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Candidiasis; Cytosine; Etoposide; Fever; Fluconazole; Focal Infection; Humans; Leukemia, Myelomonocytic, Acute; Liver Diseases; Male; Neutropenia; Remission Induction; Tomography, X-Ray Computed	1993
Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimens. Gynecologic oncology, 1993, Volume: 50, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Creatinine; Cyclophosphamide; Epithelium; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Parenteral; Kidney; Middle Aged; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Treatment Outcome	1993
Chronic oral etoposide in small-cell lung cancer: clinical and pharmacokinetic results. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:7 Topics: Administration, Oral; Aged; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia	1993
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisolone; Prognosis; Prospective Studies; Thioguanine	1993
Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia. American journal of hematology, 1996, Volume: 51, Issue:1 Topics: Acute Disease; Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Catheterization, Central Venous; Cross Infection; Cytarabine; Daunorubicin; Disease Susceptibility; Etoposide; Female; Fever; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neutropenia; Patient Discharge; Safety; Treatment Outcome	1996
Reversible renal impairment during leukocytosis induced by G-CSF in non-Hodgkin's lymphoma. American journal of hematology, 1996, Volume: 51, Issue:4 Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Intestinal Neoplasms; Kidney Diseases; Leukocytosis; Lymphoma, Large B-Cell, Diffuse; Male; Neutropenia; Prednisolone; Recombinant Proteins; Remission Induction; Vinca Alkaloids	1996
High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer. American journal of clinical oncology, 1996, Volume: 19, Issue:2 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Creatinine; Cyclophosphamide; Diarrhea; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Nausea; Neutropenia; Remission Induction; Transplantation, Autologous; Treatment Outcome; Vomiting	1996
Extensive stage small cell lung cancer: determining suitability for outpatient management of febrile neutropenia. Seminars in oncology, 1996, Volume: 23, Issue:2 Topics: Adrenal Gland Neoplasms; Ambulatory Care; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Decision Making; Etoposide; Female; Fever; Hospitalization; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neutropenia	1996
Recurrent exacerbation of acne by granulocyte colony-stimulating factor administration. Journal of the American Academy of Dermatology, 1996, Volume: 34, Issue:5 Pt 1 Topics: Acne Vulgaris; Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neutropenia; Recurrence; Testicular Neoplasms	1996
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study. Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6 Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia	1996
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas. Annals of hematology, 1997, Volume: 74, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methylprednisolone; Middle Aged; Myeloproliferative Disorders; Neutropenia; Salvage Therapy; Survival Rate; Time Factors	1997
A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi. Cancer, 1997, Mar-15, Volume: 79, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Pilot Projects; Prednisone; Remission Induction; Survival Analysis; Treatment Failure; Vincristine	1997
Tolerability and efficacy of GM-CSF [Leucomax] in patients with small cell lung cancer treated with intensive chemotherapy. Medical oncology (Northwood, London, England), 1996, Volume: 13, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chi-Square Distribution; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis	1996
Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot study. International journal of radiation oncology, biology, physics, 1997, Apr-01, Volume: 38, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Pilot Projects	1997
The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Mesna; Middle Aged; Neuroectodermal Tumors, Primitive; Neutropenia; Sarcoma, Ewing; Vincristine	1997
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Transplantation, Autologous; Vincristine	1998
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Child; Drug Administration Schedule; Etoposide; Female; Fever; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neutropenia; Osteosarcoma; Pilot Projects; Thrombocytopenia	1998
Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy. European journal of gynaecological oncology, 1998, Volume: 19, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aztreonam; Bacterial Infections; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Etoposide; Female; Fever; Fluorouracil; Genital Neoplasms, Female; Humans; Injections, Intravenous; Middle Aged; Monobactams; Neutropenia; Penicillins; Piperacillin; Retrospective Studies; Treatment Outcome; Urine	1998
High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:14 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Diseases; Male; Neutropenia; Retinal Neoplasms; Retinoblastoma	1997
Therapeutic drug monitoring of 21-day oral etoposide in patients with advanced non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:7 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Monitoring; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies	1998
Neutropenic colitis as a complication of high-dose chemotherapy for refractory testicular cancer. Japanese journal of clinical oncology, 1998, Volume: 28, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Colitis; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Seminoma; Testicular Neoplasms	1998
A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report. International journal of radiation oncology, biology, physics, 1998, Oct-01, Volume: 42, Issue:3 Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Pilot Projects; Radiotherapy Dosage; Survival Analysis; Thrombocytopenia; Treatment Failure	1998
Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:12 Topics: Administration, Oral; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents, Phytogenic; Biological Availability; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia	1995
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype. Haematologica, 1998, Volume: 83, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Rate; Treatment Outcome; Vincristine	1998
[A case of neutropenic enterocolitis in high dose chemotherapy with peripheral blood stem cell transplantation for relapsed testicular tumor]. Hinyokika kiyo. Acta urologica Japonica, 1998, Volume: 44, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Enterocolitis; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neutropenia; Seminoma; Testicular Neoplasms	1998
Early detection by ultrasound scan of severe post-chemotherapy gut complications in patients with acute leukemia. Haematologica, 1999, Volume: 84, Issue:3 Topics: Acute Disease; Adult; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dilatation, Pathologic; Enterocolitis; Etoposide; Female; Gallbladder Diseases; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Intubation, Gastrointestinal; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Ultrasonography	1999
Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens. Bone marrow transplantation, 1999, Volume: 23, Issue:2 Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Component Removal; Blood Transfusion, Autologous; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplastic Cells, Circulating; Neutropenia; Retrospective Studies; Transplantation, Autologous	1999
Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma. Leukemia & lymphoma, 1999, Volume: 34, Issue:5-6 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carmustine; Cyclophosphamide; Etoposide; Female; Fever; Hodgkin Disease; Humans; Length of Stay; Lymphoma; Male; Middle Aged; Neutropenia; Ofloxacin; Opportunistic Infections; Rifampin; Salvage Therapy	1999
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma. Medical and pediatric oncology, 2000, Volume: 34, Issue:4 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Transfusion; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dactinomycin; Etoposide; Female; Fever; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Platelet Transfusion; Retrospective Studies; Sarcoma; Sepsis; Treatment Outcome; Vincristine	2000
Complications of systemic chemotherapy as treatment of retinoblastoma. Archives of ophthalmology (Chicago, Ill. : 1960), 2000, Volume: 118, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclosporine; Cytarabine; Etoposide; Female; Fever; Humans; Infant; Male; Methotrexate; Neutropenia; Organophosphorus Compounds; Retinal Neoplasms; Retinoblastoma; Thrombocytopenia; Vincristine	2000
A novel combination of paclitaxel, etoposide, and cyclophosphamide for stem cell mobilization and tumor cytoreduction in ovarian cancer. Journal of hematotherapy & stem cell research, 2000, Volume: 9, Issue:2 Topics: Alopecia; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Carcinoma, Papillary; Cyclophosphamide; Endometrial Neoplasms; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Klebsiella Infections; Leukapheresis; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Serous Membrane; Taxoids	2000
Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue. International journal of oncology, 2000, Volume: 17, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intercellular Adhesion Molecule-1; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Neutrophils; Recombinant Proteins; Solubility	2000
Expression of CD11b/CD18 on neutrophils after consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell transplantation. International journal of oncology, 2000, Volume: 17, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; CD18 Antigens; Combined Modality Therapy; Cytarabine; Etoposide; Female; Filgrastim; Gene Expression Regulation, Leukemic; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Macrophage-1 Antigen; Male; Melphalan; Middle Aged; Neoplasm Proteins; Neutropenia; Recombinant Proteins; Remission Induction	2000
Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:6 Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Etoposide; Fungemia; Humans; Ifosfamide; Immunocompromised Host; Infant; Leukemia, Myeloid; Neutropenia; Saccharomyces cerevisiae; Yeast, Dried	2000
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:2 Topics: Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Interactions; Epilepsy; Etoposide; Female; Glioma; Hematologic Tests; Humans; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Thrombocytopenia; Valproic Acid	2001
[Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of German prospective randomised trial HIT'91]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2001, Volume: 5, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Etoposide; Germany; Humans; Ifosfamide; Lomustine; Medulloblastoma; Mesna; Nervous System Diseases; Neutropenia; Postoperative Period; Prospective Studies; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome; Vincristine	2001
Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Ciprofloxacin; Cyclophosphamide; Doxorubicin; Endpoint Determination; Etoposide; Fever; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Neutropenia; Palliative Care; Randomized Controlled Trials as Topic; Research Design; Roxithromycin	2001
High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells. Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infections; Male; Melphalan; Middle Aged; Neutropenia; Radiotherapy, Adjuvant; Retrospective Studies; Risk; Safety; Salvage Therapy; Survival Analysis; Survival Rate; Transplantation Conditioning; Treatment Outcome	2001
Reply to the article "Editorial comments on 'reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'", by P. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:3 Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Ciprofloxacin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Etoposide; Fever; Humans; Lung Neoplasms; Neutropenia; Palliative Care; Randomized Controlled Trials as Topic; Roxithromycin	2002
Use of GM-CSF in children after high-dose chemotherapy. Medical and pediatric oncology. Supplement, 1992, Volume: 2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infant; Leukocyte Count; Male; Neoplasms; Neutropenia; Platelet Transfusion; Recombinant Proteins; Remission Induction	1992
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer. Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Remission Induction; Survival Rate; Vomiting	1992
Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderly. Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 2 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Vincristine	1992
Treatment of recurrent and metastatic head and neck cancer with cisplatin/etoposide/bleomycin. Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 5 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Creatinine; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycins; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Survival Rate	1992
Acremonium infection in a neutropenic patient. The Journal of infection, 1992, Volume: 25, Issue:1 Topics: Acremonium; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Peripheral; Catheters, Indwelling; Cytarabine; Doxorubicin; Etoposide; Female; Fungemia; Humans; Middle Aged; Neutropenia	1992
Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy. International journal of cell cloning, 1990, Volume: 8 Suppl 1 Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Specimen Collection; Bone Marrow Transplantation; Carmustine; Colony-Stimulating Factors; Cyclophosphamide; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocytes; Hodgkin Disease; Humans; Male; Neutropenia; Neutrophils; Pain; Recombinant Proteins	1990
Carboplatin dose optimization. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Drug Administration Schedule; Etoposide; Humans; Neutropenia; Organoplatinum Compounds; Thrombocytopenia	1990
An application of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in a case of hepatocellular carcinoma combined with liver cirrhosis in which leukopenia developed after chemoembolization. Gastroenterologia Japonica, 1991, Volume: 26, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Neutropenia; Recombinant Proteins	1991
Fournier's gangrene: a hazard of chemotherapy in AIDS. Clinical oncology (Royal College of Radiologists (Great Britain)), 1991, Volume: 3, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Etoposide; Fasciitis; Gangrene; Humans; Male; Necrosis; Neutropenia; Perineum; Sarcoma, Kaposi; Scrotum; Skin Neoplasms	1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Half-Life; Hospitalization; Humans; Infant; Leukocyte Count; Male; Neutropenia; Neutrophils; Platelet Count; Recombinant Proteins; Thrombocytopenia	1991
Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer. Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Vincristine	1990
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Pilot Projects; Remission Induction; Survival Rate; Thrombocytopenia	1990
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report. Seminars in oncology, 1990, Volume: 17, Issue:2 Suppl 4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prognosis	1990
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Pilot Projects; Thrombocytopenia	1990
Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer. American journal of clinical oncology, 1990, Volume: 13, Issue:5 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Etoposide; Female; Gastrectomy; Humans; Male; Middle Aged; Neutropenia; Stomach Neoplasms; Thrombocytopenia	1990
Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; France; Humans; Leukemia, Myeloid, Acute; Life Tables; Middle Aged; Neutropenia; Survival Rate	1990
Toxicity of etoposide, doxorubicin, and cisplatin in gastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Neutropenia; Remission Induction; Stomach Neoplasms	1990
Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide. Cancer, 1990, Jul-15, Volume: 66, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Male; Middle Aged; Neutropenia; Tumor Lysis Syndrome	1990
Transplacental effects of maternal cancer chemotherapy. Case report. British journal of obstetrics and gynaecology, 1989, Volume: 96, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Hair; Hair Diseases; Humans; Infant, Newborn; Infant, Premature, Diseases; Maternal-Fetal Exchange; Neutropenia; Pregnancy; Pregnancy Complications, Neoplastic	1989
Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pneumonia; Radiation Injuries; Remission Induction; Thrombocytopenia; Vincristine	1989
Phase I study of a carboplatin-etoposide combination in advanced thoracic cancer. European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neutropenia; Organoplatinum Compounds; Pancytopenia; Thrombocytopenia	1988
Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Hearing Loss; Humans; Infant; Neuroblastoma; Neutropenia; Pilot Projects; Water-Electrolyte Imbalance	1988
Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study). Archives of disease in childhood, 1987, Volume: 62, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Infections; Leukemia, Lymphoid; Male; Neutropenia; Pilot Projects; Thioguanine; Thrombocytopenia	1987
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease. Annals of internal medicine, 1986, Volume: 104, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Recurrence; Thrombocytopenia	1986